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SUMMARY
The highly developed and specialized anatomical and physiological character-
istics observed for eukaryotes in general and mammals in particular are underwritten
by an elaborate and intricate process of genome regulation. This precise control of the
location, timing and amplitude of gene expression is achieved by a variety of genetic
and epigenetic tools and mechanisms. Such tools include cis- and trans- transcrip-
tional regulation, epigenetic marks and chromosomal conformation in the nucleus
[78, 79].
While all these regulatory mechanisms have been extensively studied, our under-
standing of the complex and diverse associations between various epigenetic marks
and genetic elements with genome regulatory systems has remained incomplete. How-
ever, the last few years have seen a profound development in two areas that have sig-
nificantly improved the depth and breadth to which their functions and relationships
can be understood; 1) Next generation sequencing (NGS) and 2) its application in
the genome-wide profiling of multiple DNA elements and functional factors. These
include suites of histone modifications, transcription factors, DNA methylations and
DNAse hypersensitive sites in various mammalian tissues by the ENCODE consor-
tium and other research laboratories.
The objective of this thesis has been to apply bioinformatic computational and
statistical tools to analyze and interpret various recent high throughput datasets from
a combination of Next generation sequencing and Chromatin immune precipitation
(ChIP-seq)experiments. These datasets have been analyzed to further our under-
standing of the dynamics of gene regulation in humans particularly as it relates to
repetitive DNA, cis-regulation and DNA methylation. The thesis thus resides at the
xviii
intersection of three major areas in the overarching domain of human genome reg-
ulation; transposable elements, cis-regulatory elements and epigenetics. It explores
how those three aspects of regulation relate with gene expression and the functional
implications of those interactions.
From this analysis of high throughput datasets, the thesis provides new insights
into; 1) the relationship between the transposable element environment of human
genes and their expression, 2) the role of mammalian-wide interspersed repeats (MIRs)
in the function of human enhancers and enhancement of tissue-specific functions, 3)
the existence and function of composite cis-regulatory elements and 4) the dynamics
and relationship between human gene-body DNA methylation and gene expression.
The specific advances of my research in the field of human genome regulation are
summarized as follows:
Research advance 1: With both TE fractions and GL being highly correlated
to gene length, this study evaluated the two parameters together and teased apart
their relative contributions to the gene expression parameters of tissue-specificity and
expression levels. By showing that GL is strongly correlated with overall expression
level but weakly correlated with the breadth of expression, this study elicited evidence
for the selection hypothesis [23] that attributes the compactness of highly expressed
genes to selection for economy of transcription as opposed to the genomic design
hypothesis [135]. Infact, TE fractions of human genes were shown to be more anti-
correlated to gene expression levels, suggesting that TEs, rather than GL might be
more important targets of selection for transcriptional economy. Finally, MIRs were
found to be the only TEs that positively associate with tissue-specific gene expres-
sion. Relevance of TEs environment for gene expression was confirmed and distinct
mechanisms by which they may contribute to genome regulation were adduced.
Research advance 2: Mammalian-wide interspersed repeats (MIRs), previously
shown to be related to tissue-specific gene expression [61], are shown to execute this
xix
function primarily through enhancers. This study found MIRs to be significantly
enriched within enhancers and reports many novel MIR-derived enhancers. Indeed,
the density of enhancer-MIRs around genes is shown to be significantly related to
both their level of expression, their tissue specificity and to be involved in tissue-
specific cellular functions. MIRs within enhancers are shown to possess significantly
higher numbers of transcriptional factor binding sites (TFBSs) relative to the genomic
background, a finding that might explain their co-option into enhancers and thus their
longstanding conservation and wide distribution in the mammalian clade.
Research advance 3: This research adduced evidence that confirmed previous
postulations that distinctions between different classes of cis-regulatory elements may
not be definitive and that different elements might share regulatory features and
mechanisms. Taking boundary elements and enhancers within the human CD4+ T
cells as examples, we identified 174 composite cis-regulatory elements, for which both
enhancers and boundary elements are co-located. These composite cis-regulatory
elements possess unique chromatin environments and regulatory features and are
revealed to facilitate cell-type specific functions.
Research advance 4: This research used the approach of a meta-analysis of
new high throughput chromatin, methylation and gene expression datasets to address
aspects of the long standing DNA methylation paradox [63]. Contrary to previous
knowledge [2, 4, 56, 83, 88, 108], it is shown that the relationship between gene-body
methylation and gene expression levels is not linear but actually non-monotonic (bell
shaped). These results confirm that gene-body DNA methylation does serve to repress
spurious intragenic transcription. However, they also illustrate that role to be only
epiphenomenal, with gene-body methylation levels being predominantly determined
by the accessibility of the DNA to methylating enzyme complexes rather than by an




1.1 TE environment and gene expression regulation
A gene’s architecture and context includes the nature and conformation of its pro-
moter region, its 5’ and 3’UTRs, the numbers and lengths of its exons and introns, its
epigenetic modifications and its genomic surroundings, i.e. its upstream and down-
stream neighborhood. All the above components of a gene’s architecture are hugely
influenced by the DNA sequence composition of those components. The relationship
between gene architecture and gene expression has been and remains a subject of
continuing interest for genome analysis.
As such there have been several studies to try and understand how a gene’s ar-
chitecture, particularly its length (a parameter which captures most of its features),
affects its expression. Forexample, there are currently two leading hypothesis ex-
plaining the relationship between gene length and gene expression. The first was
proposed by Castillo-Davis et al. in 2002. Their study observed that in humans and
worms, gene length, as represented by intron length, was negatively correlated with
the level of gene expression. They explained this trend, using their “selection hy-
pothesis” [23]. This hypothesis posits that highly expressed genes are shorter due to
selective forces that operate in favor of minimizing the energy and time expended dur-
ing their transcription. Subsequently, this inverse relationship between gene length
and expression level was confirmed by a number of studies, providing support for the
selection hypothesis [27, 28, 33, 87, 114, 128]. The second hypothesis [136], known
as the “genomic design” hypothesis, explains the shorter length of highly expressed
genes in view of the fact that these genes also tend to be broadly expressed across
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numerous tissues. This broad expression implies simpler regulation, which requires
fewer regulatory sequence elements (and hence shorter genes), than genes expressed
in a more narrow tissue-specific fashion.
However, the human genome is replete with transposable elements, with almost
half of it being constituted by them [82, 132]. Several research strands have also
shown these TEs to impact gene expression in multiple ways. Indeed, while most
TEs reside outside of genes, there is a considerable fraction within introns and a
few within exons. Consequently, TE gene fractions are highly correlated with gene
length[61]. As such, the effect of gene length on expression as explained by the above
two leading hypotheses cannot be fully understood without assessing the contribution
of TEs to that relationship. This thesis thus jointly analyzes TEs and gene length in
order to tease apart the relative contribution of each on gene expression levels. Infer-
ences from that analysis are then used to first evaluate the validity of the selection
hypothesis vis a vis the genomic design hypothesis. Secondly, that analysis enables
the elucidation of a possible mechanism by which selection might work to optimize
the relationship between gene length and gene expression. Additionally and finally,
since tissue-specificity and breadth of expression are central reference points for both
hypotheses, this thesis uncovers and considers the special relationship between a spe-
cific class of TEs (Mammalian-wide interspersed repeats - MIRs) and tissue-specific
gene expression.
1.2 Exaptation of MIRs into enhancers
Different classes of TEs have been shown to have unique effects on specific aspects
of gene expression. Forexample, weakly expressed genes generally contain low SINE
and high LINE densities [133] while the most highly expressed human genes are
enriched for SINEs (Alu) [133] and depleted for L1 elements [51]. Indeed highly and
broadly expressed housekeeping genes are identifiable by their TE-content which is
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rich in Alus and poor in L1s [34]. Consequently, TEs are known to influence distinct
biological functions [15, 16]. As such, the distribution of TEs is regulated and thus
TEs are non-randomly distributed in mammalian genomes. The transposition of TEs
across genomes enables the replication and spreading of their features, which contain
regulatory and coding sequences. This puts such sequences in the bodies or vicinity
of genes found in the neighborhoods of the TE transposition loci, resulting in the
formation of regulatory networks [39] and multiple other cases where TEs serve as
coding or regulatory sequences for genes[48, 92]. This process, by which a formerly
selfish or parasitic element sequence is utilized to provide regulatory and/or coding
functions that increase the host’s fitness is known as exaptation. There are thus three
different fates that could occur to transposed TEs. First, they could be exapted if
transposed to locations where they serve to improve the hosts fitness. Secondly, they
could be gradually removed from the genome if their transposition occurs in locations
where their effects are deleterious. Thirdly, they may be kept in the genome if they
land in neutral locations where they are neither beneficial nor deleterious. In this
later case, they often accumulate epigenetic features like DNA methylation to prevent
further transposition and eventually lose their identity and potency through random
mutations. Now, Mammalian-wide interspersed repeats (MIRs), an ancient family of
tRNA derived SINEs [67, 119] are the oldest TEs in mammals. This long standing
high conservation in mammalian genomes suggests MIRs to encode some unknown
regulatory function [115]. Indeed succeeding studies have shown individual MIRs to
donate transcription factor binding sites [106, 139], enhancers [92, 125], microRNAs
[105] and cis natural anti sense transcripts [29].
However, our understanding of the reasons for the genome-wide high conservation
of MIRs has remained incomplete. Nevertheless, they have been observed as the only
TEs having a positive relationship with tissue-specific gene expression [61] as shown
in the preceding part of this thesis. This study evaluates the relationship between
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MIRs and the only other elements that have been associated with tissue-specific
expression –enhancers [17, 54]. This genome-wide examination reveals MIRs to be
concentrated in enhancers and to have important tissue-specific regulatory functions
which they exercise through enhancers. These results suggest a plausible rationale
for the exaptation of MIRs and thus their long standing conservation.
1.3 Diversity of cis-regulatory elements
cis-regulatory elements are often noncoding DNA sequences that orchestrate the
proper timing and level of expression of proximal genes. They frequently contain
binding sites for transcription factors[58] which in turn directly interact with gene
promoters to regulate expression. cis-regulatory elements are typically small and
modular in nature i.e. function in a manner autonomous of their location or orienta-
tion relative to their target genes[12]. This small size and modular nature has enabled
the study of cis-regulatory elements using their reporter constructs in transgenic an-
imals. Consequently, several types of cis-regulatory elements have been identified
and described, including transcriptional promoters[46], promoter-tethering elements
[18], enhancers [5], silencers[81], locus control regions(LCRs)[50, 86] and boundary
elements[127] which include enhancer-blocking insulators[69]. Insulators are DNA se-
quence elements that prevent inappropriate interactions between adjacent chromatin
domains that may have distinct functions. Forexample, a transcriptionally active
domain in a specific cell-type might lie close to a transcriptionally inactive domain.
Much of the inappropriate cross-talk between chromatin domains is driven by en-
hancers because transcription factors bound on enhancers can loop over long genomic
distances to reach promoters, giving enhancers the ability to influence the expression
of distal promoters. It is such interactions that are regulated by insulators. As such,
boundaries and enhancers have hitherto not only been considered to be functionally
antagonistic, but also to also occupy distinct and separate loci in the genome. There
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have however been studies suggesting that insulators might exploit the functionality
of other genomic regulatory elements like enhancers [44] and that the distinctions
between various classes of cis-regulatory elements might be exaggerated[44]. In this
thesis, we address this question of the existence of what we designate as composite cis-
regulatory elements from the perspective of boundary elements and enhancers. Using
boundary elements and enhancers predicted computationally from high throughput
genome-wide epigenetic datasets [37, 141], we screen for composite sites that simul-
taneously contain both elements. The thesis also examines the chromatin, gene ex-
pression as well as functional signatures of these elements.
1.4 The DNA methylation paradox
Identical DNA sequences in different cell-types or individuals often present varia-
tions in their expression and resultant phenotypes. This phenomenon is attributable
to various complex layers of molecules that associate with DNA sequences. These
include histone modifications, DNA methylation and transcription factors. Collec-
tively, these molecules and their extensive operational mechanisms are referred to
as epigenetics[9, 80]. Thus efforts to understand genome regulation and phenotypic
determination are centered on the two modes in which gene expression outcomes are
encoded; DNA sequences and epigenetic patterns. DNA methylation, together with
histone modifications and transcription factors, are the most widely studied com-
ponents of epigenetics. For DNA methylation, a methyl group is added to the 5’
position of the cytosine pyrimidine ring, mostly at CpG sites i.e. sites where a cy-
tosine is followed by a guanine, the two being joined by a phosphate group. DNA
methylation is an important and wide spread epigenetic mark whose effects have been
observed in various biological processes including embryogenesis and differentiation
[47], X-inactivation [53], imprinting [85] and repression of viral and repeat sequences
[138]. Indeed, variations in DNA methylation patterns have been implicated in several
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human diseases [59, 110] including cancer [35]. Clear negative associations between
DNA methylation states in promoter regions and gene expression levels have been ob-
served in a number of studies [24, 47, 74]. As a result, methylation is largely depleted
from the promoter regions of genes. In contrast, DNA methylation is abundant in
the gene-bodies of genes and is reportedly positively correlated with gene expression
[2, 4, 56, 83, 88, 108] even though there are indications that it could interfere with
transcription elongation [90]. This apparent contradiction between the activities of
DNA methylation in promoters versus gene bodies has been referred to as the DNA
methylation paradox [63]. While there are cases of individual genes for which gene-
body DNA methylation regulates intragenic promoter activity [94], it is not clear
what the role of gene-body DNA methylation is, and neither is there an understand-
ing of the dynamics of its deposition within the gene bodies. In this thesis, we rely on
several epigenetic datasets first to evaluate the actual relationship between gene-body
DNA methylation and gene expression. Secondly, the thesis assesses the role role of
gene-body DNA methylation. Finally, we collate the different analytical results and
generate a model that illuminates the dynamics involved in the deposition of DNA
methylation within gene bodies.
1.5 Overview of dissertation
This thesis constitutes the intersections of three major aspects of human genome
regulation; transposable elements, epigenetics (as represented by DNA methylation
and histone modifications) and cis-regulatory elements. It applies computational and
statistical analysis on several next generation sequencing datasets to answer specific
biological questions aimed at advancing our understanding of the dynamics of human
genome regulation. Particularly, the thesis examines how the above three aspects
relate to the expression and function of genes (Figure 1.1).












Figure 1.1: Aspects of human genome regulation covered by thesis. Thesis
examines how TEs (Chapters 2 and 3), cis-regulatory elements (Chapters 4) and
Epigenetics (Chapters 5) relate to gene expression and function.
of genes on their architecture and expression. It evaluates the unique effects of the
various TE classes on three parameters of gene expression; level of expression, breadth
of expression, and tissue specificity of expression. It further teases apart the relative
effects of the correlated features of TEs and gene length on gene expression, followed
by an evaluation of how those results inform the two leading hypotheses that relate
gene length to gene expression levels.
CHAPTER 3 focuses on one family of transposable elements, mammalian-wide
interspersed repeats (MIRs) and how they affect tissue-specific gene expression. It
evaluates the genomic distribution of these elements and establishes enhancers as the
primary platform through which MIRs exercise their gene regulatory function, chiefly
through the donation of transcription factor binding sites. The functional relevance of
these enhancer-based MIRs is then illustrated by their profound role in erythropoiesis
and its related processes in the K562 cell-line.
CHAPTER 4 assesses the nature and diversity of cis-regulatory elements. Specif-
ically, it establishes the existence of functional composite (boundary and enhancer)
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cis-regulatory elements in the human genome, thereby confirming the long held pos-
tulation that various classes of cis-regulatory elements often share mechanisms and
their identities may sometimes overlap. The chapter performs a census of these com-
posite elements and finds 174 across the genome. Finally the chapter uses CD4+ T
cells to elicit evidence that these composite cis-regulatory elements facilitate cell-type
specific functions related to inflammation and immune response.
CHAPTER 5 considers the relationship between gene-body DNA methylation and
gene expression and addresses the longstanding DNA methylation paradox. Using a
meta analysis of several epigenetic datasets, it shows that the relationship between
gene-body DNA methylation and gene expression is not linear as previously thought,
but rather non-monotonic and bell shaped. Furthermore, the chapter confirms gene-
body DNA methylation to regulate spurious transcription from intragenic sites. How-
ever it shows that role to be epiphenomenal to an independent process of gene-body




EFFECT OF THE TRANSPOSABLE ELEMENT
ENVIRONMENT OF HUMAN GENES ON GENE
LENGTH AND EXPRESSION
2.1 Abstract
Independent lines of investigation have documented effects of both transposable ele-
ments (TEs) and gene length (GL) on gene expression. However, TE gene fractions
are highly correlated with GL, suggesting that they can not be considered indepen-
dently. We evaluated the TE environment of human genes and GL jointly in an
attempt to tease apart their relative effects. TE gene fractions and GL were com-
pared to the overall level of gene expression and the breadth of expression across
tissues. GL is strongly correlated with overall expression level, but weakly correlated
with the breadth of expression, confirming the selection hypothesis that attributes
the compactness of highly expressed genes to selection for economy of transcription.
However, TE gene fractions overall, and for the L1 family in particular, show stronger
anti-correlations with expression level than GL, indicating that GL may not be the
most important target of selection for transcriptional economy. These results suggest
a specific mechanism, removal of TEs, by which highly expressed genes are selectively
tuned for efficiency. MIR elements are the only family of TEs with gene fractions
that show a positive correlation with tissue-specific expression, suggesting that they
may provide regulatory sequences that help to control human gene expression. Con-
sistent with this notion, MIR fractions are relatively enriched close to transcription
start sites and associated with co-expression in specific sets of related tissues. Our
results confirm the overall relevance of the TE environment to gene expression and
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point to distinct mechanisms by which different TE families may contribute to gene
regulation.
2.2 Introduction
The relationship between gene architecture and gene expression has been and remains
a subject of continuing interest for genome analysis. In a pioneering study, Castillo-
Davis et al. (2002) observed that, for human and worm genes, intron length was
negatively correlated with the level of expression. In other words, shorter genes were
found to be expressed at higher levels and longer genes at lower levels. To explain this
trend, the authors formulated the “selection hypothesis” [23]. This hypothesis posits
that highly expressed genes are shorter due to selective forces that operate in favor
of minimizing the energy and time expended during transcription. Subsequently, the
relationship between gene length and expression level was confirmed by a number of
studies, providing support for the selection hypothesis [27, 28, 33, 87, 114, 128].
In 2004, Vinogradov also observed that compact genes were more highly expressed,
but he offered a different explanation for this trend [136]. Vinogradov proposed
the “genomic design” hypothesis, which postulates that the shorter length of highly
expressed genes is better explained by the fact that these genes also tend to be
broadly expressed across numerous tissues and thus have simpler regulation, and
require fewer regulatory sequence elements, than genes expressed in a more narrow
tissue-specific fashion. In other words, the relative paucity of regulatory elements in
broadly expressed genes explains their shorter average length. The genomic design
hypothesis rests on the notion that the apparent correlation between gene length and
the level of expression actually reflects a relationship between gene length and the
breadth of expression – i.e. the number of tissues in which a gene is expressed.
The selection hypothesis and the genomic design hypothesis make distinct testable
predictions regarding the relationship between gene length and gene expression. The
10
selection hypothesis predicts the strongest correlation between gene length and the
overall expression level, whereas the genomic design hypothesis predicts the strongest
correlation between gene length and the breadth of expression. A recent study used
these predictions to evaluate the competing hypotheses and found that the selection
hypothesis serves as the best explanation for the relationship between gene length
and expression [19].
While the aforementioned studies were ongoing, there was an independent line of
research investigating the relationship between gene architecture and gene expression
from a different perspective. In eukaryotic genomes, and particularly for mammalian
genomes, gene architecture is substantially influenced by the presence of transposable
element (TE) derived sequences. TE derived sequences are extremely abundant in
mammalian genomes; at least 45% of the human genome is made up of TE sequences
[82, 132]. In addition, TE sequences are non-randomly distributed across genomes. In
the human genome, Alu (SINE) elements are enriched in GC- and gene-rich regions,
whereas L1 (LINE) elements are enriched in low GC and gene-poor regions [82, 118].
Finally, individual genes can vary tremendously with respect to the amount and
identity of TE sequences that they harbor.
Over the last several years, a series of studies have called attention to a relation-
ship between the transposable element (TE) environment in-and-around genes and
the level and breadth of gene expression. In 2003, the human genome sequence was
used together with expression data to construct a human transcriptome map [133].
This map identified co-located clusters of highly expressed genes with specific genomic
characteristics. These clusters were gene dense, had high GC-content, were enriched
for SINEs, Alu elements in particular, and had low LINE densities. The same study
found clusters of weakly expressed genes with low SINE and high LINE densities.
Shortly thereafter, Han et al. confirmed that the most highly expressed human genes
were depleted for L1 elements and demonstrated a mechanism that could partially
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explain this pattern [51]. They showed that L1 elements can disrupt transcriptional
elongation based on the presence of strong polyA signals in their sequences. Kim et
al. made an important contribution to this body of work by distinguishing between
TE effects on the level of expression and the breadth of expression [72]. They mea-
sured overall expression level as the peak level of expression over all tissues (PE) and
expression breadth (BE) as the number of tissues in which a gene is expressed over
some basal threshold. Their work revealed that Alu element gene densities are more
highly correlated with BE, whereas L1 densities are most negatively correlated with
PE. These results suggested that different families of TEs may have specific effects on
different aspects of gene expression. Consistent with these results, Eller et al. showed
that highly and broadly expressed housekeeping genes can be distinguished by their
TE-content, being primarily enriched for Alus and depleted for L1s [34]. In addition
to the level and breadth of expression, the TE environment of mammalian genes has
also been related to expression in cancer tissues [84] and the evolutionary divergence
of gene expression [104].
As of yet, no one has attempted to consider these two areas of investigation to-
gether: 1) the relationship between gene length and expression and 2) the relationship
between TE environment and gene expression. In this study, we attempt to disentan-
gle the effects of gene length and TE environment on gene expression and to evaluate
the relative influences of each on expression. Having considered their effects sepa-
rately, we then more thoroughly evaluate the connections between gene architecture
and the selection versus genomic design hypotheses.
2.3 Methods
2.3.1 Defining gene loci
To accommodate alternative splice variants of human genes and compute TE frac-
tions for specific loci, we define genes here as distinct transcriptional units (TUs) -
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genomic regions encompassing all overlapping transcripts from the start of the 5’-
most exon to the end of the 3’-most exon (Supplementary Figure A.1A). To that end,
we downloaded RefSeq annotations for the March 2006 build of the human genome
reference sequence (NCBI build 36.1; UCSC hg18) from the UCSC Genome Browser
[68, 109]. A total of 32,128 RefSeq transcripts were merged into 19,123 TUs that
represent distinct gene loci.
2.3.2 Determining genic and intergenic TE fractions
To determine the fractions of human genes (TUs) that are made up of TE sequences,
human TEs were broken down into six of the major human TE classes or families
according to the Repbase classification system [67, 76] – Alu, MIR, L1, L2, DNA and
LTR. RepeatMasker (http://www.repeatmasker.org) annotations of the genomic co-
ordinates of these TEs were used to map them onto their co-located genes. For each
TE type, its fraction in a gene was computed as the number of base pairs occupied by
a TE as a fraction of all base pairs in the gene. For each human gene, its intergenic
region was taken as the union of the regions upstream of the transcription start site
and downstream of the termination site to the genomic mid-point between the adja-
cent upstream and downstream genes. TE intergentic fractions were then calculated
in the same way as for TE genic fractions based on these genomic coordinates.
2.3.3 Gene expression data
To measure gene expression in different tissues, we used the Gene Expression Atlas
from the Genomics Institute of the Novartis Research Foundation, which consists
of Affymetrix microarray gene expression values for 44,776 probe sets across 79 hu-
man tissues [123]. Affymetrix probe sets were mapped onto their corresponding TUs
based on their genomic location coordinates. As suggested previously [121], probes
that mapped to more than one TU were discarded, and for TUs with more than one
mapped probe, the average expression level per tissue was used. This resulted into
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a final dataset of 15,658 TUs to which expression data could be assigned. Expres-
sion data are represented as signal intensity units based on the Affymetrix MAS4
processing and normalization algorithm suite.
2.3.4 Measurement of gene length (GL) and gene expression parameters
For each TU, the GL was calculated by simply subtracting its start coordinate along
the chromosome from the end coordinate and then subjecting the difference to a log2
transformation. The microarray expression data described above were used to cal-
culate three measurements of gene expression: peak expression level (PE), breadth
of expression (BE) and tissue-specific expression (TS). To obtain PE, the signal in-
tensity value from the tissue where the TU is most highly expressed was selected for
each TU and subjected to a log2 transformation to accommodate the vast disparity
(range=197,652.4 signal intensity units) in the peak levels of expression between TUs.
For each TU, the BE was calculated as the number of tissues in which the expression
of the TU exceeded a threshold of 350 expression signal intensity units [64]. For each
TU, a TS index was computed as described [148]. The value of TS varies between 0
and 1 and reflects the number of tissues where the TU is overly expressed relative to






where N is the number of tissues and xi represents a TU’s signal intensity value in
each tissue i divided by the maximum signal intensity value of the TU across all
tissues.
2.3.5 Comparative analysis of GL, TE gene fractions and gene expression
parameters
The relative effects of GL and the TE gene environment on gene expression were
evaluated using pairwise and multiple linear regression analyses where GL and the
TE-fractions were the independent variables and the gene expression parameters PE,
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BE and TS were the dependent variables. For these analyses, parameter values were
ranked and binned in order to smooth the signal and reduce background noise. For
each parameter, the 15,658 TUs were ranked and divided into 100 bins of approxi-
mately equal size (∼157 TUs per bin). Parameter values were averaged for each bin
and the averages were used to populate ordered vectors of values (n=100). Vectors
that represent independent and dependent variables were then compared using pair-
wise regression or combined into a multiple regression model. All data were treated
using the same ranking and binning procedure so that the relative effects of the in-
dependent variables on the dependent variables could be comparatively evaluated.
2.3.6 Gene expression clustering analysis
Tissue-specific expression patterns for the top 10% MIR-rich genes were analyzed
using hierarchical clustering based on pairwise Euclidean distances between vectors
of tissue-specific gene expression levels over 79 tissues. This analysis was conducted
using the program Genesis [122] with signal intensity values median normalized across
tissues.
2.3.7 Statistical analyses used
For the pairwise regression analyses, independent and dependent variable vectors were
compared using pairwise Pearson correlation (r -values in figs. 2.1 to 2.5; individual
coefficient of determination R2-values in Tables tables 1 to 5) and the significance of
the correlations (P -values in figs. 2.1 to 2.5 and Tables tables 1 to 5) were determined
using the Student’s t-distribution. Partial correlation analyses were used to control
for the effects of correlated pairs of independent variables (Tables tables 1, 2 and 4).
Multiple regression analyses were conducted to determine the combined coefficient of
determination for all TE fractions (R2-values in Table 3) and the partial correlation
values (r -values in Table 3). Significance values for the multiple coefficients of de-
termination (‘All TE’ P-values in Table 3) were determined using the F distribution.
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Significance values for the partial correlations (P -values in Tables tables 1 to 4) were
determined using the Student’s t-distribution.
2.4 Results and discussion
2.4.1 TE environment of human genes
Gene and TE annotations from the reference sequence of the human genome (NCBI
build 36.1, UCSC hg18) were analyzed together to characterize the TE environment
of human genes. A total of 19,123 transcriptional units (TUs), which reconcile al-
ternative splice variants and represent discrete gene loci, were derived from RefSeq
annotations as described in the Materials and Methods (see also Supplementary Fig-
ure A.1A). The fraction of each human gene locus derived from TE sequences was
determined using RepeatMasker annotations. Six of the most abundant classes (fam-
ilies) of TEs were considered in this analysis - Alu, MIR, L1, L2, DNA and LTR. The
frequencies of other classes of TEs were found to be too low to substantially affect
the overall TE environment of human genes.
Human genes show an average TE fraction of 34% and a standard deviation (SD)
of 18% (Figure 2.1A). Human TE gene fractions show a broad distribution that is
fairly bell shaped with the exception of a sharp peak of genes that are devoid of TEs
(0% TE fraction in Figure 2.1A). The presence of these TE-free genes is consistent
with the removal of genic TEs by purifying selection [116]. The TE gene fractions
observed for individual TE families are consistent with previous results [97] in which
Alu elements were found to be the most abundant family of TEs in human genes,
whereas LTR elements are found in the lowest frequency within human genes (Sup-
plementary Figure A.1B). The length distributions of TEs in genes (Supplementary
Table ST1) reveal that they are mostly short (<400bp) as would be expected in tran-
scribed regions where long TEs are less tolerated owing to their higher propensity to
be deleterious.
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Figure 2.1: TE fractions in and around human genes. (A) Distributions of
intergenic (green) and genic (red) TE fractions. (B) Relationship between intergenic
TE fractions and the corresponding genic TE fractions. (C) Relationship between
intergenic TE fractions and gene length (green) and relationship between genic TE
fractions and gene length (red). Pearson correlation coefficient values (r) along with
their significance values (P) are shown for all pairwise regressions.
Overall, intergenic regions show higher TE-fractions (average=46% Figure 2.1A)
and also have a more normal distribution with lower variation than seen for genic
regions (SD=14% Figure 2.1A). For individual human genes, genic and intergenic
TE fractions are highly positively correlated (r=0.95, p=6.3x10-53), consistent with
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Table 1: Relationship between the local TE environment and gene length.a
TE fractions within genes (genic) and between genes (intergenic) are correlated with
GL (gene length).b Partial correlation between genic TE fractions and gene length
controlling for intergenic TE fractions.c Partial correlation between intergenic TE
fractions and gene length controlling for genic TE fractions.
TE fractions r P-value
GL
Genic TEa 0.87 1.04E-32
Intergenic TEa 0.55 1.40E -09
Genic TE — Intergenic TEb 0.82 6.80E-45
Intergenic TE — Genic TEc -0.18 7.02E-02
the notion that the local genomic environment strongly influences TE gene fractions
[82, 118].
2.4.2 TE fractions are related to gene length
As noted in the introduction, the relationship between gene length (GL) and expres-
sion has been investigated separately from the relationship between the TE environ-
ment of genes and their expression. However, GL and gene TE fractions may be
related if genes increase in length due, at least in part, to an accumulation of TE
derived sequences. If genes increase in length due to the acquisition of TEs, then
we expect to see a positive correlation between gene TE fractions and GL. On the
other hand, if GL increases via mechanisms that do not involve TEs, there should
be no correlation between gene TE fractions and GL. To distinguish between these
two possibilities, we compared the TE fractions of human genes to their length (as
described in Materials and Methods).
When all human TEs are considered together, there is a strong and significantly
positive correlation between gene TE fractions and GL (r=0.87, P=1.0x10-32 Fig-
ure 2.1C). While only 0.55% of the average GL for the bin with the 1% shortest genes
is constituted by TEs, the percentage progressively increases to 39.73% for the bin
with the top 1% longest genes, a >72 fold increase in the average fractions of genes
occupied by TEs. However, the positive relationship between gene TE fractions and
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GL is not strictly monotonic. Specifically, in 77% of all genes, the percentage of
GL constituted by TEs progressively increases from 0.55% in genes of about 850bp
to 44.79% for genes spanning about 70.9kb (>81 fold increase in gene TE fraction)
(Figure 2.1C). For the remaining genes beyond this length (23% of all genes), the
percentage of GL constituted by TEs levels off and remains more or less constant
with increasing length.
As noted in the previous section, TE genic and intergenic fractions are highly cor-
related (Figure 2.1B). These data are consistent with previous studies showing that
TE fractions and family distributions differ among genomic compartments and thus
may depend on regional factors such as GC-content and recombination rate [97, 133].
Therefore, it is possible that the relationship between genic TE fractions and gene
length simply reflects such regional genomic features. To test for this possibility, we
compared intergenic TE fractions to gene length. Intergenic TE fractions are sig-
nificantly positively correlated with gene length (r=0.55, P=1.4x10-9); however, the
correlation is substantially weaker than seen for genic TE fractions and the slope of
the relationship is far more flat (Figure 2.1C). Furthermore, partial correlation analy-
sis shows that TE genic fractions remain positively correlated with gene length when
intergenic TE fractions are controlled for, whereas the positive correlation between
intergenic TE fractions and gene length disappears when genic TE fractions are con-
trolled for (Table 1). In other words, the relationship between TE gene fractions and
gene length does appear to have some gene-specific, as opposed to genomic regional,
component.
To evaluate the correlation between TE genic fractions and gene length more
closely, we focused on individual TE families and found that Alus dominate the level-
ling off in gene TE fractions seen for the longest genes. Alus are the most abundant TE
sequence within gene boundaries (Supplementary Figure A.1B), and Alus also show a
unique TE fraction distribution with gene length. The fraction of Alus within genes
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rises sharply and peaks for mid-size genes (∼23.3kb) followed by an almost equally
precipitous decline in frequency, yielding a bell-shaped distribution (Figure 2.2A and
Supplementary Figure A.2A). However, the distribution of TE gene fractions for all
other TE families analyzed tends to be generally linear in relation to GL (Figure 2.2B,
Supplementary Figure A.2B-F), increasing from an average percentage of 0.34% in
the shortest genes, to 32.83% in the longest genes (a >96 fold increase in the fractions
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Figure 2.2: Relationships between the Alu fractions of human genes, gene
length (GL) and GC-content. (A) Relationships between Alu gene fractions and
GL. (B) Relationship between TE gene fractions for all TEs except Alu and GL.
(C) Relationship between GC-content and GL. (D) Relationships between Alu gene
fraction and GC-content. Pearson correlation coefficient values (r) along with their
significance values (P) are shown for all pairwise regressions.
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Table 2: Effect of GC-content on the relationship between Alu genic frations
and gene length.a Alu genic fractions and genic GC-content values are correlated
with GL (gene length).b Partial correlation analyses control for effect of GC-content
on Alu fractions (Alu |GC) and Alu fractions on GC-content (GC |Alu) respectively.
Featurea r P-value Controlb r P-value
GL
Alu 0.45 1.32E-06 Alu — GC 0.58 1.69E-12
GC -0.92 5.93E-42 GC — Alu -0.94 2.99E-152
It is not immediately apparent while Alu fractions, unique among all classes of
TEs considered here, decline for the longest genes. One possibility is that Alus are
known to be prevalent in GC-rich regions, while larger genes (introns) tend to have
lower GC-content (Figure 2.2C). Thus, it may be that the decline in Alu content for
longer genes is based on regional genomic biases in GC-content. If this is the case,
then genes with low GC-content should also have low Alu fractions and vice versa. We
found that genes with low GC-content do in fact have lower Alu content as expected
(Figure 2.2D). However, the relationship between genic Alu fractions and GC-content
is not monotonic; Alu fractions peak for genes in the middle of the GC-content range
and decrease for both low and high GC-content genes. We performed partial correla-
tion in an attempt to further tease apart the relationship between Alu gene fractions
and GC-content as they relate to gene length. GC-content is much more strongly
correlated with gene length than Alu fractions are (Figure 2.2A and 2.2C). If the
relationship of Alu genic fractions with gene length mainly reflects regional changes
in GC-content, then the correlation of Alu fractions with gene length should decrease
when GC-content is controlled for. However, when GC-content is controlled for with
partial correlation, the positive correlation between Alu gene fractions and gene length
actually increases (Table 2). Similarly, when Alu gene fractions are controlled for the
correlation between GC-content and gene length becomes more negative. These data
suggest that both Alu gene fractions and GC-content are independently related, to
some extent, with gene length in the human genome.
Overall, the positive correlations between TE gene fractions and GL indicate that
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longer genes have disproportionately more TEs relative to other sequence elements.
Considering all TE families together, TEs make up only 0.55% of the shortest genes
and yet account for 40% of the increase in GL when assessed in the longest genes.
For 3
4
of all genes, the contribution of TEs to increases in GL is >45%. These results
underscore the contributions of TEs to the length differences among human genes,
and suggest that the influences of TE environment and GL on gene expression can
not be adequately considered separately.
2.4.3 TE gene environment and the selection hypothesis
In order to relate the TE environment of human genes and GL to gene expression,
three expression parameters for human genes were measured using microarray data
over 79 tissues as described in the Materials and Methods: 1) peak expression (PE),
2) breadth of expression (BE) and 3) tissue-specific expression (TS). PE is the maxi-
mum expression level observed for a gene over all 79 tissues and is taken to represent
the overall gene expression level; BE is the number of tissues in which a gene can be
considered to be expressed, and TS is a measure of tissue-specificity described previ-
ously [148]. PE and BE were measured here because they can be used to distinguish
between the selection versus genomic design hypotheses. The selection hypothesis
predicts a stronger positive correlation of PE with GL, whereas the genomic design
hypothesis predicts a stronger correlation of BE with GL. However, BE has been
criticized as an overly simplistic measure that may not distinguish genes that are
expressed in the same sets of tissues albeit at very different relative levels. For this
reason, we also use a measure of TS that explicitly reflects the number of tissues where
a gene is overly expressed relative to its expression in other tissues (see Materials and
Methods). Genes overly expressed in a few tissues (i.e. tissue-specific genes) have
high TS indices while more broadly and evenly expressed genes have low values of
TS.
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Table 3: The relationship between TE fractions, gene length and gene ex-
pression.a R2 (The coefficient of determination) is the fraction of variability in each
expression parameter that can be attributed to the variability in each sequence fea-
ture (individual TE families, GL or all TEs combined). b r is the partial correlation
of each feature with the expression parameters, taking into account the presence of
the other elements. For each expression parameter, the TEs and GL are ranked by
their predictive value for the parameter.
Expression 
parameter 








 All TEs 0.78 < 2.2E-16  -0.13 2.1E-01 
 L1 0.75 < 2.2E-16  -0.86 2.6E-63 
 LTR 0.60 < 2.2E-16  -0.20 4.5E-02 
PE GL 0.48 1.1E-15 -0.13 2.2E-01 
 DNA 0.29 4.2E-09 -0.01 9.4E-01 
 L2 0.27 2.0E-08 -0.25 1.4E-02 
 MIR 0.06 6.3E-03 0.25 1.1E-02 
 Alu 0.03 5.0E-02 0.32 1.1E-03 
      
 All TEs 0.76 < 2.2E-16  -0.10 3.1E-01 
 Alu 0.59 < 2.2E-16 0.52 3.0E-09 
 LTR 0.57 < 2.2E-16 -0.37 1.0E-04 
BE L1 0.47 2.8E-15 -0.52 2.4E-09 
 MIR 0.12 2.2E-04 -0.28 3.6E-03 
 GL 0.04 3.2E-02 0.15 1.5E-01 
 L2 0.02 7.4E-02 0.08 4.4E-01 
 DNA 0.01 1.3E-01 0.14 1.7E-01 
      
 All TEs 0.66 < 2.2E-16 -0.32 8.8E-04 
 L1 0.63 < 2.2E-16  -0.67 9.5E-19 
 GL 0.53 < 2.2E-16 -0.05 6.3E-01 
TS L2 0.30 3.0E-09 -0.21 3.3E-02 
 Alu 0.29 5.0E-09 -0.13 2.2E-01 
 LTR 0.28 9.4E-09 -0.24 1.8E-02 
 MIR 0.27 2.1E-08 0.31 1.6E-03 
 DNA 0.24 1.8E-07 -0.04 7.3E-01 
 
Regression analysis was used to individually compare values of these expression
parameters to TE gene fractions for all six families and GL ( figs. 2.3 to 2.5), and
the effect of TE gene fractions and GL were also considered jointly using multiple
23
regression (Table 3). Consistent with previous results [19, 33], GL can be seen to
have a much stronger association with PE than BE. While 48% of the variability
in PE is attributable to GL, only about 4% of the variability in BE is attributable
to GL (Table 3). Furthermore, it can be seen that the non-monotonic shape of the
relationship between GL and PE (Figure 2.3H) is similar to what has been reported
previously [19] and also closely resembles the shape of the Alu gene fraction versus
PE distribution (Figure 2.3A). The strongest individual TE family correlation with
PE is the negative correlation seen for L1 fraction versus PE (Figure 2.3C). L1 also
has the largest negative partial correlation value with PE in the multiple regression
analysis as well as the largest coefficient of determination (Table 3). When all TEs
are analyzed together, 78% of the variability in PE can be attributed to variability
in TE gene fractions, while only 48% is attributable to variability in GL (Table 3).
While these data do lend support to the selection hypothesis, they also indicate
that TE derived sequences within genes are more highly correlated with their expres-
sion level than the overall gene length. Thus, the selective mechanism for streamlining
highly expressed genes may be related more to the elimination, or shortening, of TE
sequences per se rather than the overall shortening of genes.
2.4.4 TE gene environment and the genomic design hypothesis
The relationship between GL and BE seen here is generally weak; GL has one of
the lower individual correlations with BE (Figure 2.3G), and variability in GL only
contributes 9% of the variability seen in BE (Table 1). In addition, the results show
that while all the longest genes are narrowly expressed, there are about as many
compact narrowly expressed genes as there are compact broadly expressed genes
(Figure 2.4H). Even more surprising is the fact that the partial correlation value
for GL versus BE is positive, albeit marginally (Table 3), and not negative as can
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Figure 2.3: TE fractions, GL and the peak level of expression
(PE).Relationships between the TE gene fractions for (A)-Alu, (B)-MIR, (C)-L1,
(D)-L2, (E)-DNA, (F)-LTR and (G)-All TEs and the PE of human genes. (H) Re-
lationship between GL and PE. Pearson correlation coefficient values (r) along with
their significance values (p) are shown for all pairwise regressions.
To interrogate the genomic design hypothesis more closely, we used TS as an alter-
nate measure for the tissue-specificity of expression. The genomic design hypothesis
posits that increasing gene length is based on the requirement for additional regula-
tory sequences in genes that are expressed more narrowly. Thus in the case of TS,
a positive correlation is expected between GL and TS; in other words, longer genes
are expected to be more tissue-specific. For the pairwise regression analysis, there
is actually a strongly negative correlation between GL and TS (Figure 2.5H). This
negative trend holds when the TE fractions are controlled for in the partial correla-
tion, and GL also has a high coefficient of determination for TS (Table 3). It should
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be noted that the negative correlation between GL and TS may be related to the
analytical formulation used to compute TS (see Materials and Methods), since genes
with high expression levels in one or a few tissues (i.e. high PE) will often, but not
always, have high TS as well. Nevertheless, when taken together, the data for both
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Figure 2.4: TE fractions, GL and the breadth of expression (BE). Relation-
ships between the TE gene fractions for (A)-Alu, (B)-MIR, (C)-L1, (D)-L2, (E)-DNA,
(F)-LTR and (G)-All TEs and the BE of human genes. (H) Relationship between GL
and BE. Pearson correlation coefficient values (r) along with their significance values
(p) are shown for all pairwise regressions.
With respect to the TEs, there are strongly positive (Alu – Figure 2.4A) and
negative (L1 – Figure 2.4C) correlations between TE gene fractions and BE, and
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76% of the variability in BE can be attributed to variability in all TE gene fractions
(Table 3). Overall, TE gene fractions also have the highest coefficient of determination
for TS. Consistent with what was previously shown for PE, these data suggest that
the combinatorial impact of TEs in human genes is more important than the overall
gene length with respect to the number of tissues in which a gene is expressed and
the tissue-specificity of genes.
2.4.5 L1 elements and gene expression levels
As described previously, the data analyzed here provide support for the selection
hypothesis, since GL is more strongly (negatively) correlated with PE than BE. How-
ever, the strongest negative correlation with PE in the pairwise regression analysis
is seen for L1 gene fractions (Figure 2.3C). L1 also has the highest negative partial
correlation with PE in the multiple regression analysis and the highest coefficient
of determination (Table 3); 75% of the variability in PE is attributable to L1 gene
fractions compared to the 48% explained by GL. Thus, L1 gene fractions are more
predictive of PE than GL, indicating that variation in the gene fractions of L1s is
associated with a higher change in gene expression than variation in GL.
It is also possible that regional genomic features, such as GC-content, contribute
to the apparent effect of L1 gene content on PE. It is known that L1 elements are
enriched in GC-poor regions [82, 118], whereas GC-content is strongly positively
correlated with PE and BE [136]. Thus, one may expect to see the kind of negative
correlations between L1 and PE/BE seen here based solely on regional biases in GC-
content. We performed partial correlation to separate the effects of L1 gene fractions
and GC-content on both PE and BE. When we control for GC-content, the partial
correlation of L1 fractions with PE remains highly significant (Table 4). Conversely,
when we control for L1 fractions, the partial correlation of GC with PE is rendered
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Figure 2.5: TE fractions, GL and tissue-specific expression (TS). Relation-
ships between the TE gene fractions for (A)-Alu, (B)-MIR, (C)-L1, (D)-L2, (E)-DNA,
(F)-LTR and (G)-All TEs and the TS of human genes. (H) Relationship between GL
and TS. Pearson correlation coefficient values (r) along with their significance values
(p) are shown for all pairwise regressions.
relatedness with BE and partial correlation analysis does not remove either effect
(Table 4). Thus, the relationship between L1 gene fractions and PE/BE can not
be explained solely by the genomic distribution of L1s among different GC-content
regions.
L1 elements are an abundant and recently active family of LINEs that make up
17% of the human genome sequence [82, 132]. Experimental studies have demon-
strated that the presence of L1 sequences within genes can lower transcriptional
activity [51, 129]. The effect of the presence of L1s on PE observed here may be
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Table 4: Effect of GC-content on the relationship between L1 genic frac-
tions and gene expression. a L1 genic fractions and genic GC-content values are
correlated with the expression parameters PE (peak expression ), BE (breadth of ex-
pression) and TS (tissue-specificity). b Partial correlation analyses control for effect




 r P-value Control
b
 r P-value 
PE 
L1 -0.87 1.69E-31 L1 | GC -0.73 1.3E-25 
GC 0.69 1.20E-15 GC | L1 0.12 2.2E-01 
BE 
L1 -0.69 1.38E-15 L1 | GC -0.44 1.7E-06 
GC -0.21 2.00E-02 GC | L1 0.44 1.4E-06 
TS 
L1 -0.79 3.12E-23 L1 | GC -0.77 3.0E-32 
GC 0.32 6.81E-04 GC | L1 -0.03 7.5E-01 
 
attributed to the fact that the disruptive activity of L1s on transcription inhibits
gene expression more than an overall increase in gene length does. However, this
finding is not entirely inconsistent with the selection hypothesis, rather it suggests
a specific mechanism, namely the elimination of L1 sequences, for selectively tuning
highly expressed genes that would also result in an overall decrease in their length.
2.4.6 MIR elements and tissue-specific gene expression
The genomic design hypothesis posits a requirement for additional regulatory se-
quence elements that facilitate tissue-specific expression, which in turn leads to an
increase in GL. However, data reported here show that the presence of such regula-
tory elements does not necessarily result in an overall increase in GL as predicted the
genome design hypothesis (Figure 2.5H). In light of this realization, we sought to eval-
uate whether any specific TE sequence elements might be related to the regulatory
complexity entailed by tissue-specific genes. Out of all the TE families evaluated,
MIRs are the only elements that show the expected trends for the genome design
hypothesis for both BE and TS. The fraction of MIRs in human genes is negatively
correlated with BE (Figure 2.4B) and positively correlated with TS (Figure 2.5B)
as expected. In fact, MIRs are the only TEs positively correlated with TS, and the
increase in the MIR gene fraction is not linear with increasing TS. At the high range
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of TS (>0.7; 58% of all genes), the positive correlation of MIR gene fractions to TS
is even stronger (r=0.78, P=3.7x10-18).
These results are interesting in light of what is already known about MIRs. MIR
elements (mammalian wide interspersed repeats) are an ancient family of tRNA de-
rived SINEs [67, 119], and they have previously been implicated as having regulatory
significance in a number of studies. Initially, human MIR sequences were shown to be
highly conserved over time suggesting that they may encode some unknown regula-
tory function [115]. Subsequently, MIR derived sequences have been shown to donate
transcription factor binding sites [106, 139], enhancer sequences [92], microRNAs [105]
and cis natural anti sense transcripts [29] to the human genome. In addition, it has
been shown that, while TEs are generally depleted from introns, MIRs are actually
significantly enriched within genes that might require subtle regulation of transcript
levels or precise activation timing, such as growth factors, cytokines, hormones, and
genes involved in the immune response [117]. Such genes would be expected to be
largely tissue-specific.
If MIRs donate regulatory sequences to tissue-specific genes, then one may expect
to observe relative increases in MIR density in the regulatory regions upstream and
downstream of transcription start sites (TSS). To evaluate this possibility, we took
the top 10% tissue-specific genes and evaluated their MIR frequencies at 1kb intervals
along a 20kb window surrounding the gene TSS. As with all other TEs, MIRs show a
marked decline in frequency most proximal to the TSS. However, MIRs show a unique
pattern of enrichment both upstream and downstream of the TSS, just outside the
proximal promoter region, compared to other families of TEs. In fact, MIRs are
the only elements that show local frequency maxima at -1kb and +2kb with respect
to the TSS. All other TEs show their maxima in more distal regions from the TSS
(Figure 2.6). This pattern is consistent with a unique regulatory role for MIRs,
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Figure 2.6: The local frequency maxima of TE densities around the TSS
of tissue-specific genes. The red line shows the density distribution of MIRs
around transcription start sites. Colored dots show the locations of the local frequency
maxima for the different TE classes/families.
If the regulatory effect of genic MIRs is based on the donation of shared transcrip-
tion factor binding sites, then one may expect the tissues in which MIR-rich genes
are expressed to be similar. We evaluated this prediction in two ways. First, we took
the top 10% MIR rich genes and for each gene we determined the tissue in which
it was maximally expressed. The observed frequency distribution for these tissues
was compared to a randomized distribution of the same number of genes among all
tissues in the microarray data set analyzed here using a X 2 test. The observed distri-
bution is far from random (Supplementary Figure A.3; (X 2=1,406.8 P=1.1x10-242),
and there are a number of specific tissues, and groups of related tissues, that are over-
represented, particularly liver, blood related tissues, reproductive tissues and nervous
tissues. Second, we clustered the expression patterns of the top 10% MIR rich genes
using hierarchical clustering based on the Euclidean distances between their gene ex-
pression patterns over 79 tissues. Several of the resulting clusters show groups of
MIR rich genes that are markedly over-expressed among these same related groups















Cluster 1: Nervous tissues  
 
Cluster 4: Reproductive tissues 
 
Cluster 3: Lung, Kidney, Liver tissues 
 
Cluster 2: Blood tissues 
Figure 2.7: Heatmap showing co-expression of MIR-rich genes. MIR-rich
genes hierarchically clustered into groups of similar expression profiles across tissues.
The clusters show maximum expression in related sets of tissues.
MIRs are a relatively ancient family of TEs that are conserved among mammals
including mouse. We evaluated TE gene fraction and expression data for mouse,
in the same as was done for humans, to see if the same trends in the relationship
between MIR gene fractions and tissue-specificity hold for mouse elements. As is the
case for the human genome, mouse MIR elements are the only family of TEs with
genic fractions that are significantly positively correlated with TS (Table 5). This
suggests the possibility that MIR elements have been conserved among mammalian
genomes, at least to some extent, by virtue of their regulatory contributions.
The genomic design hypothesis predicts that additional regulatory sequence ele-
ments required by tissue-specific genes will lead to an increase in their overall length.
However, with respect to MIRs, our analysis suggests that the enrichment of regula-
tory elements in tissue-specific genes does not lead to an increase in the overall length
of genes. Rather, the regulatory complexity required by tissue-specific genes may be
achieved in some cases via the donation of a few key sequence elements provided by
TEs that come pre-equipped with existing regulatory capacity.
2.5 Conclusions
The architecture of human genes has important implications for how they are ex-
pressed. Previous studies on this topic have focused separately on the influences of
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Table 5: Relationship between genic TE fractions and tissue-specificity
in mouse.a Genic TE fractions for mouse TE families were correlated with tissue-
specificity in the same way as done for human TE families (see Figure 2.5).










GL or the TE environment on gene expression. Here, we show that these two factors
are closely related, and we consider them jointly in an attempt to dissect their indi-
vidual contributions. Consistent with previous results, we observed GL to be strongly
correlated with PE and less so with BE. We also show that GL is strongly correlated
with TS but not in the direction that is expected according to the genomic design
hypothesis. These data provide strong support for the selection hypothesis. However,
we show that the TE fraction of human genes has a stronger overall effect on gene
expression than does GL. Considered together, TE gene fractions explain 78%, 76%
and 66% of the variability observed for PE, BE and TS, in all cases, greater than
what is seen for GL. We also uncover examples where individual TE families, L1s and
MIRs respectively, have marked effects on the level and breadth of gene expression.
Consideration of intergenic TE fractions and GC-content together with TE gene
fractions suggests that the relationships between TE gene fractions and gene length
and expression are not solely related to regional genomic processes. However, there
may be other as yet undetected regional genomic factors that could mitigate the
apparent relationships between TE gene fractions and gene length and expression.
Nevertheless, the results reported here underscore the potential regulatory implica-
tions of the TE environment of human genes and also suggest specific mechanisms
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for how TEs may contribute to gene regulation.
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CHAPTER 3
MIRS REGULATE HUMAN GENE EXPRESSION AND
FUNCTION PREDOMINANTLY VIA ENHANCERS
3.1 Abstract
MIRs are the oldest Transposable Elements (TEs) in the human genome and are
mammalian -wide. Their long standing conservation and universal occurrence within
the mammalian lineage suggests an essential functional role. Infact, they are the
only TEs that are positively correlated to tissue-specific gene expression genome-
wide. However, this genome-wide tissue-specific association has also been observed
for enhancers. This coincident similar correlation between both MIRs and enhancers
to tissue-specificity suggests that MIRs might be strongly linked to enhancers. To
test this, we examined the relationship between MIRs and enhancers in terms of both
genomic location and function. This analysis revealed MIRs to be highly concentrated
in enhancers and to constitute a significant part of the core of enhancers. Likewise,
we found significantly more enhancers to be linked to MIRs than would be expected
by chance. Many novel MIR-derived enhancers are reported and so are numerous
MIRs that are linked to enhancers, complete with a similar chromatin epigenetic
pattern as that of canonical enhancers. Moreover, MIRs are found to be substantial
donors of functional transcription factor binding sites to enhancers, a likely reason
for their evolutionary co-option into enhancer bodies. Furthermore, MIRs located
in enhancers show significant relationships with gene expression levels, tissue-specific
gene expression and tissue-specific cellular functions. Taken together, these data
reveal enhancers to be the primary cis-regulatory platform from which MIRs exercise
their regulatory function in the human genome.
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3.2 Introduction
Transposable elements (TEs) are very abundant in eukaryotic genomes, particularly
mammalian genomes. Indeed, at least 45% of the human genome is made up of
TE sequences [82, 132] which are non-randomly distributed across genomes. In the
human genome forexample, Alu (SINE) elements are predominantly found in GC-
and gene-rich regions, while L1 (LINE) elements are most prevalent in low GC and
gene-poor regions [82, 120]. This ubiquitous but non-random distribution has resulted
in the exaptation [49] of TE sequences for several functions such as the rewiring of
novel regulatory networks [39, 113] and the subsequent evolutionary divergence in
eukaryotic genome regulation [16, 51].
Different families of TEs have been shown to have specific effects on different
aspects of gene expression. Forexample, weakly expressed genes generally contain
low SINE and high LINE densities while the most highly expressed human genes are
enriched for SINEs (Alu) [133] and depleted for L1 elements [51]. Indeed, a mechanism
that partially accounts for L1 repression of gene expression has been demonstrated,
in which L1 polyA signals disrupt transcriptional elongation [51]. Additionally, Alu
elements are significantly associated with the breadth of gene expression across tissues
while L1s are negatively correlated with the levels of expression [61, 72]. Thus highly
and broadly expressed housekeeping genes are identifiable by their TE-content which
is rich in Alus and poor in L1s [34].
However, Mammalian-wide Interspersed Repeats (MIRs) are the only TEs that
show a positive association with tissue-specific gene expression[61]. MIR elements,
which several studies have revealed to have regulatory roles, are an ancient family
of tRNA derived SINEs [67, 119]. Indeed, their long standing high conservation in
mammalian genomes was for long the basis of the expectation that they encode some
unknown regulatory function [115]. Succeeding studies have shown MIRs to donate
transcription factor binding sites [106, 139], enhancers [92, 125], microRNAs [105] and
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cis natural anti sense transcripts [29] to the human genome. Furthermore, while TEs
are generally depleted from introns, MIRs are actually significantly enriched within
tissue-specific genes [117]. This strong association of MIR elements to tissue-specific
gene expression is noteworthy because it coincides with what has been observed for
the epigenetic chromatin state of enhancers.
Chromatin state has for long been known as an indicator of the activity or oth-
erwise of genes and other cis-regulatory elements [101, 145]. The chromatin state
at most cis-regulatory elements like promoters and CTCF-binding at insulators are
largely invariant across cell types. Curiously though, enhancers possess highly cell
type-specific histone modification patterns [54]. Thus enhancers are also related to
the spatiotemporal specificity of gene expression [17, 54]. We hypothesized this global
coincident association of both MIRs and enhancers to tissue-specific gene expres-
sion to be at least in part a consequence of MIR sequences frequently acting ei-
ther as enhancers and/or constituting fragments of enhancer- sequences. This would
be consistent with previously reported specific examples of TE-derived enhancers
[38, 88, 92, 95].
We thus sought to perform a specific genome-wide assessment of the relative preva-
lence of MIRs within enhancer sequences as well as the mechanistic basis and func-
tional consequences of this interaction. We found MIRs to not only be highly con-
centrated in enhancers, but to also constitute a significant part of the core of genic
enhancers. Indeed, this analysis identifies many more novel MIRs than previously
reported [57, 125] that act as independent enhancers, complete with the chromatin
profile of canonical enhancers. Furthermore, we report MIRs to be the major donors of
transcription factor binding sites (TFBSs) within enhancers, with consequent effects
on both the level and tissue-specificity of gene expression. Using the erythroid K562
cell-line as an example, we show MIR-enhancers to be involved in the modulation of
several tissue-specific biological processes related to erythropoiesis.
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3.3 Methods
3.3.1 Co-locating enhancers and MIRs
We used two sets of 24,538 and 36,550 putative transcriptional enhancers in the K562
and HeLa cell-lines respectively [54]. These enhancers were predicted as ENCODE
regions showing presence of coactivator protein p300 which is known to co-localize at
enhancers [62]. These p300 binding sites were themselves located using a chromatin
immunoprecipitation-based microarray method (ChIP-chip) [55, 60]. We considered
the span of enhancers to be the 8kb region around the predicted enhancer mid-points
which is about the range of the characteristic chromatin pattern at enhancers. Con-
currently, we also used the RepeatMasker (http://www.repeatmasker.org/) annota-
tions of the genomic coordinates of MIR elements as identified by the Repbase clas-
sification system [123, 148]. These MIR annotations on the human genome assembly
(NCBI build 36.1; UCSC hg18) were downloaded from the UCSC Genome Browser
[68, 109]. Another set of 19,536 transcriptional units derived from RefSeq gene anno-
tations as defined in Jjingo et al [61] was used to assess MIR densities within genes.
For both the K562 and HeLa cell-lines, regions of overlap between MIR genomic coor-
dinates and regions of interest were then determined using a perl script. This overlap
was performed separately for four different types of genomic elements/regions; genic
enhancers, genic non-enhancer regions (genic background), non-genic enhancers and
the core 200bp region around predicted enhancer mid-points. For each of the regions,
the density of MIRs was computed either as the fraction of the length of each region
in basepairs that is occupied by MIRs or their fold enrichment within the regions
relative to the local genomic background.
3.3.2 Histone modification profiles
Genome-wide ChIP-seq [62] data for 8 histone modification marks (H3K4me1, H3K27ac,
H3K36me3, H3K9ac, H3K4me2, H3K4me3, H4K20me1 and H3K27me3) in the K562
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and HeLa-S3 cell-lines was taken from the ‘ENCODE histone modification tracks’ of
the UCSC Genome Browser (assembly hg19). The data covers a range of 12.4-33.9
million sites for each histone mark in each cell-line. Genomic loci of 20kb centered on
canonical enhancers (all predicted enhancers), MIR-enhancers (enhancers with MIR-
derived cores) and enhancer-MIRs (MIRs 4kb of enhancer cores) were then evaluated.
Counts of each histone modification within each 500bp window across the 20kb re-
gion were then computed and their profiles represented as fold enrichments relative
to counts in the genomic background. The congruence of modification profiles be-
tween canonical enhancers and both enhancer-MIRs and MIR-enhancers was then
assessed in two ways. First a comparison of the fold enrichments of corresponding
windows across the 20kb region was done between canonical enhancers and both MIR-
enhancers and enhancer-MIRs (Figure 3.2, Supplementary figure B.2). Secondly, rank
ordered correlations from the above comparison were weighted by the slope of their
line-of-best-fit to establish the order of histone mark enrichment congruence between
canonical enhancers and both MIR-enhancers and enhancer-MIRs in each cell-line
(Figure 3.2D, Supplementary figure B.3B)
3.3.3 Transcription factor sites and binding analysis
Genome-wide enhancer-MIRs transcription factor binding sites were surveyed in two
stages. First, the occurrences of nine known TFBSs for ZNF274, ISGF3, ATF3, C-
JUN, NF-E2, TFIIIC, USF2, STAT1 and CEBP were counted. This was done by
transforming the binding sites into their matching regular expression patterns and
then searching and counting those patterns in the raw sequences of all enhancers-
MIRs. The same pattern search and counting was then performed on random se-
quences of equivalent number and length as the enhancer-MIRs. These random se-
quences were generated by drawing sequences from random genomic regions. Numbers
of patterns of binding sites within enhancer-based MIRs were then compared to those
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in the random sequences using a Chi-square test in which counts of the former were
considered the observed and those of the later as the expected (Figure 3.3A, Supple-
mentary figure 3.4A). Binding sites within enhancer-MIRs that are actually bound
were assessed for transcription factors NE-F2, C-JUN, USF2 and ZNF274 in the K562
cell-line. For each transcription factor, binding locations were downloaded from the
‘ENCODE transcription factor binding tracks’ of the UCSC Genome Browser (as-
sembly hg19). The peak tracks used contain regions of statistically significant signal
enrichment from ChIP-Seq experiments. For all transcription factors, sequences of
enhancer-MIRs overlapping with TF signal peaks were compiled. To check for exis-
tence of TFBSs, these sequences were screened with the MEME motif finding software
[3] which discovers motifs de-novo. They were also checked for canonical TFBSs using
matching regular expressions of the binding sites (Figure 3.4A,B). The enrichment
of TF binding in enhancer-MIRs relative to non-enhancer-MIRs was evaluated for a
wide range of transcription factors; 39 and 43 factors in K562 and HeLa cell-lines re-
spectively (see Supplementary figure 3.4B for their identities). For each TF, the fold
enrichment was computed as the log2 of the ratio of the sum of signal values for all
peaks mapping to enhancer-MIRs to the sum of signal values for all peaks mapping
to non-enhancer-MIRs.
3.3.4 Relating gene expression and tissue-specificity to enhancers-MIRs
Two sets of gene expression data were used. The first consisted of exon microarray
data for six ENCODE cell-lines (K562, HeLa-S3, GM12878, HepG2, H7Hesc and HU-
VEC). This was taken from the ‘ENCODE Exon Array’ track of the UCSC Genome
Browser (assembly hg19) and compiled as outlined in Jjingo et al [60], resulting in
18,654 genes with expression data. The second dataset with expression data in 79 tis-
sues and cell-lines was from the Norvatis gene expression atlas [123]. It was processed
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and compiled as previously outlined [61], and consisted of 15,658 genes to which ex-
pression data could be assigned. For both datasets, a tissue-specificity index (TS) for






where N is the number of tissues and xi represents a gene’s signal intensity value
in each tissue i divided by the maximum signal intensity value of the gene across
all tissues. For each gene, the density of enhancer-MIRs in and around the gene
(from 10kb upstream to 10kb downstream) was computed by dividing the number of
enhancer-MIRs in that genomic range by the number of basepairs in the range. The
density values of the enhancer-MIRs were then divided into 100 equal bins whose
average densities were regressed against their respective average expression levels
(Figure 3.5A, Supplementary figure B.5A). Similarly, regression of the densities of
enhancer-MIRs in and around each gene (from 100kb upstream to 100kb downstream)
against tissue-specificity values of the genes was also performed after binning the data
into 100 bins. This second regression was separately done against tissue-specificity
values computed from the six ENCODE cell-lines above (Figure 3.5B, Supplementary
figure B.5B) and tissue-specificity values computed from the 79 tissues in the Norvatis
gene expression atlas (Figure 3.5C, Supplementary figure B.5C).
3.3.5 Functional analysis
The functional effects of enhancer-MIRs were evaluated using erythroid (K562)-
specific enhancer-MIRs (defined as enhancer-MIRs present in K562 and absent in
HeLa). First, we assembled all genes within 100kb of tissue-specific enhancer-MIRs,
and considered these to be associated with those enhancers. We then used a hy-
pergeometric test to check for enrichment of these enhancer-MIR associated genes
within a set of 350 genes that have been shown to be highly regulated in erythroids
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across four stages of erythropoiesis [99]. Furthermore we again used the hypergeo-
metric test to investigate if the enhancer-MIR associated genes are significantly active
in 9 erythroid (K562) cellular functions. This was done by checking for enrichment
of enhancer-MIR associated genes within sets of genes annotated to constitute the
pathways of the cellular functions. The gene sets for the 9 cellular functions (Supple-
mentary Table ST2) were obtained from the Broad Institute’s molecular signatures
database (MSigDB) collections of the gene set enrichment analysis (GSEA) software
(http://www.broadinstitute.org/gsea/msigdb/index.jsp). For one of these gene sets,
gene expression levels were previously determined at the various stages of erythro-
poiesis [1]. We compared the expression levels of enhancer-MIR associated genes in
this gene set to approximate stages of erythropoiesis (Figure 3.6B). We then used
the UCSC genome browser to illustrate enhancer-MIRs located in the locus control
region of the α-globin gene cluster which is important for haemoglobin formation
(Figure 3.6C). This cluster contains genes HBZ and HBA1 which are enhancer-MIR
associated and are differentially expressed in the various stages of erythropoiesis.
3.4 Results and discussion
3.4.1 MIRs are highly concentrated in enhancers
As noted in the introduction, MIRs are the only TEs that show a positive associa-
tion with tissue-specific gene expression [61]. Similarly, unlike other cis-regulatory
elements, enhancers are marked with highly cell type-specific histone modification
patterns [54] and are accordingly also highly related to tissue specific gene expression
[17, 54]. We thus sought to test our working hypothesis that this functional correspon-
dence between MIRs and enhancers is largely a consequence of MIR sequences either
frequently acting as enhancers and/or constituting fragments of enhancer sequences.
The genomic coordinates of 24,538 and 36,550 putative transcriptional enhancers
in the K562 and HeLa cell-lines respectively [54] were intersected with those of 19,536
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genes derived from RefSeq annotations as non-overlapping transcriptional units [61].
This yielded 1,917 and 2,090 genes with enhancers in their gene bodies in the K562
and HeLa cell-lines respectively. For each of these genes, its resident enhancers and
its non-enhancer sequences were intersected with a set of all genomic MIRs from the
UCSC Genome Browser [68, 109], yielding MIR densities within both genic enhancers
and genic non-enhancer regions. Within gene bodies, MIRs show significantly higher
densities in enhancers than in non-enhancer sequences (P -values 2.0e-16 and 5.9e-13
for K562 and HeLa cell-lines respectively) (Figure 3.1A, Supplementary figure B.1A.
MIRs have been previously reported to be enriched within genic regions of certain
genes[117]. Our data clearly reveal this genic enrichment to be strongly biased towards
enhancers. Infact, we find MIRs to be critical components of the cores of genic
enhancers, where on average MIR-derived sequences constitute 35% and 31% of the
core 200bp regions at the center of enhancers in K562 and HeLa cell-lines respectively
(Figure 3.1B, Supplementary figure 3.1B). This enrichment is 8 and 7 fold higher than
MIR density in genic non-enhancer sequences in K562 and HeLa cell-lines respectively.
To expand the investigation beyond gene bodies, we evaluated MIR enrichment
in and around all genomic enhancers. We computed the number of MIRs in and
around 20kb loci centered on all genomic enhancers (N=24,538 and 36,550 for K562 &
HeLa cell-lines respectively) and compared it to MIR enrichment in the local genomic
background. The results reveal MIRs to be highly enriched around all enhancers
genome-wide, with upto ∼35% and ∼37% more MIRs around enhancers than in the
genomic background for K562 and HeLa cell-lines respectively (X 2 = 4592, P<1.0e-16
and X 2 = 7470, P<1.0e-16) (Figure 3.1C, Supplementary figure B.1C). Thus while
MIRs have been known to donate enhancers [57, 92, 125], these data show an even
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Figure 3.1: MIRs are highly concentrated within enhancers.(A) Heat maps
showing the average MIR densities of 100 equal bins of genes in the K562 cell-line.
Upper bars show average MIR density in the genic enhancers of each bin, while lower
bars show average MIR density in the corresponding non-enhancer sequences of the
genes in the same bin. Bins are arranged left to right in decreasing MIR densities
in genes. (B) Bar graph showing the density of MIRs in the core 200bp of genic
enhancers (white bars) versus the corresponding non-enhancer sequences of the genes
(grey bars). (C) Fold enrichment plots of MIRs in and around all genic enhancers
(Red) and intergenic enhancers (Green) relative to local background (Grey).
3.4.2 Numerous MIRs are autonomous enhancers or are linked to en-
hancers
Finding MIRs to be highly concentrated within enhancers, we sought to establish
the actual numbers of MIRs that are enhancers themselves as well as those that
lie within enhancer regions. Each enhancer was originally predicted to be anchored
around a single basepair locus [54]. If this core basepair was located in a MIR,
then such a MIR was accordingly classified as an enhancer. Hence forward, we call
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these MIR-enhancers. However some MIRs do not donate the core enhancer locus
but are located within the normal approximate 8kb span enhancers (as determined
from the average genomic span of enhancer chromatin patterns surrounding the core
locus of the enhancer). These were considered enhancer-linked MIRs and are hence
forward called enhancer-MIRs. There are thus two categories of MIRs with regard
to their particular relationship with enhancers; MIR-enhancers and enhancer-MIRs.
We found 934 and 1429 MIRs to be MIR-enhancers i.e.MIRs that are enhancers in
K562 and HeLa cell-lines respectively (supplementary Table ST4). This is in contrast
to the 669 and 996 MIRs that would be expected to be enhancers in the two cell-lines
respectively, if MIRs were randomly distributed among enhancers. Thus significantly
more MIRs than expected are enhancers in both K562 and HeLa (X 2 = 105, P<1.0e-16
and X 2 = 188, P<1.0e-16 respectively).
When this analysis was expanded to include all enhancer linked MIRs i.e. enhancer-
MIRs, the extent to which enhancers are connected to MIRs became even more appar-
ent. We found 16,144 and 26,520 enhancers to be linked to MIRs in K562 and HeLa
cell-lines respectively. This is in contrast to the 6559 and 9320 enhancers that would
be expected to be linked to MIRs in the two cell-lines respectively, if enhancers were
randomly distributed among MIRs. Thus ∼2.5 and 2.9 fold more enhancers than
expected are linked to MIRs in K562 and HeLa cell-lines (X 2 = 14007, P<1.0e-16
and X 2 = 31742, P<1.0e-16 respectively). To further confirm if the MIR-enhancers
and enhancer-MIRs identified above are legitimate enhancers or are enhancer linked
respectively, we compared their chromatin environment to that of all canonical en-
hancers.
H3K4me1 and H3K27Ac have been shown to be characteristically enriched at
enhancers and are thus indicative of enhancers [30, 54, 55, 107]. We found both
enhancer-MIRs and MIR-enhancers to have enrichments of the two modifications
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Figure 3.2: The chromatin environment of MIR-enhancers is similar to that
of canonical enhancers in K562. Fold enrichment of histone modifications within
20kb regions centered on (A) Canonical enhancers and (B) MIR-enhancers. (C) Con-
gruence of histone modifications fold enrichment levels between MIR-enhancers and
canonical enhancers. (D) Rank order of correlations of modifications fold enrichments
between MIR categories and canonical enhancers weighted by slope.
Indeed, modification patterns for both categories of MIRs are highly congruous
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to that of regular enhancers in terms of position specific modification fold enrich-
ment (Figure 3.3C, Supplementary figure B.3A). However the order of histone mod-
ification congruity is tissue-specific with H3K4me1 showing the highest congruity in
K562 (Figure 3.2D, Supplementary figure B.3B -1st panel) while H3K27ac has the
highest congruity in HeLa (Supplementary figures B.3B -2nd and 3rd pannels). As
expected, enhancer-MIRs show a somewhat diminished enrichment and congruity of
the two modifications since this category includes enhancer-linked MIRs rather than
MIRs that are enhancers themselves. Interestingly, MIR-enhancers show a signifi-
cantly stronger enrichment of the enhancer distinguishing modifications H3K4me1
and H3K27Ac than the ‘canonical’ enhancers (P = 6.9e-14 and 9.6e-24; Paired T-test
for the two modifications) in K562 and HeLa cell-lines respectively. This suggests
MIR-enhancers to be the stronger relative to the average enhancer. Furthermore, the
numbers of MIR-derived enhancers identified here – 934 and 1429 (Supplementary file
2) in K562 and HeLa respectively, are significantly more than have been previously
reported [57, 125].
3.4.3 MIRs are enriched for TFBSs
Mechanistically, enhancers boost gene expression by recruiting transcription factors
(TFs) which in turn interact with promoters to recruit RNA polymerase II, hence
initiating and driving transcription [93]. Accordingly, one of the most plausible evo-
lutionary rationale for the exaptation of MIRs into enhancers and the co-opting of
MIRs into enhancer bodies would be if MIRs offered more TFBSs than would ordi-
narily be obtained from other genomic sequences.
We investigated this evolutionary possibility by performing a general survey of
the prevalence of some known TFBSs of TFs active in K562-specific cellular pro-
cesses (C-JUN, ZNF274, NF-E2) (Figure 3.3A) within enhancer-MIRs relative to
































































































Figure 3.3: Presence and activity of transcription factor binding sites in
enhancer-MIRs.(A) Number of TFBSs in enhancer-MIRs (Blue) and random ge-
nomic sequences (Grey). (B) Log2 fold enrichment of three TFs active in the K562
cell-line and bound to enhancer-MIRs relative to their binding levels to non-enhancer
MIRs in the K562 cell-line.
known TFBSs; (ISGF3, ATF3, TFIIIC, USF2, STAT1 and CEBP) (supplementary
Figure B.4A).
For 8 out of the 9 transcription factors, enhancer-MIRs possessed significantly
more TFBSs than random genomic sequences as shown by Chi-square tests (Fig-
ure 3.3A, Supplementary figure 3.4A). Using both the MEME motif finding software
[3] and regular expression searches, we find known TFBSs in TF-bound enhancer-MIR
sequences, as determined by co-location with ENCODE transcription factor ChIP-Seq
peaks (Figure 3.4A,B).
We then sought to show that this TF binding of TFBSs in enhancer-MIRs is not
only significantly higher than binding of TFBSs in non-enhancer-MIRs, but also holds
for a wide range of TFs. To do this, we compared the binding levels of each TF in
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enhancer-MIRs to those in non-enhancer-MIRs using a log2 fold enrichment index as
described in the methods section. In both K562 and HeLa, 37/39 and 38/44 TFs
respectively bind significantly more on enhancer-MIRs than on non-enhancer MIRs.
Thus enhancer-MIRs not only contain more TFBSs than random genomic sequences,
but are also actually bound significantly more than non-enhancer MIRs by a wide
range of TFs (Figure 3.3B, Supplementary figure 3.4B). Based on that evidence, we
posit that the evolutionary co-option of MIRs into enhancer bodies is atleast in part




























C-JUN 45 4 TGA(C|G)TCA 2  86% 5 
NF-E2 26 11 TCA(T|C) 19 100%  19 
ZNF274 5 5 (G|A)A(A|G)TG(T|G) 1   83%   6 
Figure 3.4: TFBSs occurring in enhancer-MIRs (A) (Column three) TFBSs
predicted denovo by MEME software from enhancer-MIR sequences. (Column five)
Known TFBSs found by regular expression searches in enhancer-MIR sequences. (B)
Examples of TFBSs for C-JUN and ZNF274 predicted denovo by MEME software
from bound sequences of enhancer-MIRs. Start column shows the starting positions
of the TFBSs in the enhancer-MIR sequences while the P-value is the probability
that the TFBS exists within the sequence by chance.
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3.4.4 Enhancer-MIRs influence gene expression and tissue-specificity
To check if the observed extensive prevalence and TF binding capacity of enhancer-
MIRs translates into genome-wide regulatory effects, we related enhancer-MIR den-
sities to two gene expression parameters; gene expression level and gene tissue-
specificity. Enhancer-MIR densities in and around each gene were computed and
the 18,654 genes were then divided into 100 equal bins. The average enhancer-MIR
densities of the bins were then regressed against their corresponding average gene ex-
pression values. For both K562 and HeLa cell-lines, the density of enhancer-MIRs in
and around genes is significantly related to gene expression levels (r=0.50, P=5.9e-08
and r=0.46, P= 7.4e-07 respectively) (Figure 3.5A, Supplementary figure 3.5A).
To assess the effects of enhancer-MIRs on tissue-specificity, a similar procedure
as that above was repeated by regressing the binned expression levels of the 18,654
genes against their corresponding tissue-specificity values across six ENCODE cell-
lines. The regressions revealed significant relationships between enhancer-MIR den-
sities and tissue specificity in both K562 and HeLa cell-lines (r=0.37, P=7.6e-05 and
r=0.27, P=2.4e-03 respectively) (Figure 3.5B, Supplementary figure 3.5B). Although
these regressions against tissue-specificity were significant, they were rather weak and
we wondered if that might not be an artifact of the few tissues used to compute the
tissue-specificity index. We thus repeated the above protocol using the15,658 genes
from the Norvatis gene expression atlas whose tissue-specificity indices were com-
puted across 79 different tissues. This regression confirmed the relationship between
enhancer-MIRs and tissue-specificity by yielding much more significant correlations in
both cell-lines (r=0.74, P=7.1e-19 and r=0.66, P=4.0e-14 respectively) (Figure 3.5C,
Supplementary figure 3.5C). Taken together, these data reveal enhancer-MIRs to have
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Figure 3.5: Effect of enhancer-MIRs on gene expression and tissue specificity
in the K562 cell-line.(A) Relationship between density of enhancer-MIRs and gene
expression levels. (B) Relationship between density of enhancer-MIRs and tissue-
specificity of gene expression across 6 ENCODE cell-lines. (C). Relationship between
density of enhancer-MIRs and tissue-specificity of gene expression across 79 tissues
from the Norvatis gene expression atlas. Pearson correlation coefficient values (r)
along with their significance values (p) are shown for all pairwise regressions.
3.4.5 Functional significance of enhancer MIRs
Since enhancer-MIRs are involved in driving tissue-specific gene expression, it is rea-
sonable to expect that there are some tissue-specific biological functions that they
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help regulate. We examined this prospect in the K562 cell-line by assessing the
functional roles of genes within 100kb of tissue-specific enhancer-MIRs. Of 19,538
non-overlapping Refseq genes, we found 3,798 (19.5%) to be associated with enhancer-
MIRs. We tested for relative enrichment of those genes within a set of 350 genes that
have been shown to be highly regulated in erythroids across four stages of erythro-
poiesis [99]. Of the 3,798 enhancer-MIR associated genes, 202 overlapped the set of
350 genes highly regulated in erythropoiesis or their close homologs. This overlap
is highly significant (P = 2.1e-57; Hypergeometric test) and suggests enhancer-MIRs
might have a profound impact on erythropoietic regulation.
We therefore broadened the analysis to include other biological processes related
to erythropoiesis. We tested for enrichment of enhancer-MIR associated genes in
nine gene sets of nine erythroid (K562) biological functions. The nine gene sets
were obtained from the Broad Institute’s molecular signatures database (MSigDB)
collections. Gene sets for 8 out of the 9 biological functions significantly overlapped
with enhancer-MIR associated genes (Figure 3.6A, Supplementary table ST2).
To further understand the impact that enhancer-MIRs might have, we considered
erythropoiesis, whose gene set has the most significant overlap with enhancer-MIR
associated genes. This erythropoiesis gene set contains genes with varying expres-
sion levels at the various stages of erythropoiesis [1]. We compared the expression
levels of enhancer-MIR associated genes (Table ST3) in this gene set to approximate
stages of erythropoiesis and found them to have varying expression levels, an indicator
that they are regulated during erythropoiesis (Figure 3.6B). We then used the UCSC
genome browser to illustrate that previously identified regulatory MIRs [65] are ac-
tually enhancer-MIRs located in the locus control region of the α-globin gene cluster
which is important for hemoglobin formation during erythropoiesis (Figure 3.6C).
This cluster contains genes HBZ and HBA1 which are enhancer-MIR associated and
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Figure 3.6: Activity of enhancer-MIR associated genes in erythropoiesis.(A)
The bars represent level of enrichment of enhancer-MIR associated genes within gene
sets of the various biological functions on the x-axis. Dotted line represents the
threshold of significance. (B) Enhancer-MIR associated genes that are differentially
expressed or regulated at the various stages of erythropoiesis (shown below the line
graph). Genes represented by each colored rectangle are shown in the box below the
developmental pathway. (C) Enhancer-MIRs in the β-globin gene cluster locus con-
trol region (LCR). UCSC trucks of enhancer-MIRs, the LCR, histone modifications,
transcription factors active in K562, Pol2, DNAse hypersensitive sites and β-globin
genes regulated by the LCR.
Furthermore, it can be seen that the locus that contains the enhancer-MIRs recruits
TFs C-JUN, ZNF274 and NF-E2 that are important for K562-specific cellular pro-
cesses [66, 70, 76, 142]. Taken together, these results suggest that K562 specific
enhancer-MIRs are probably active in the regulation of genes involved in several
K562-related biological functions in general, and erythropoiesis in particular.
53
3.5 Acknowledgments
This work was supported in part by the Fulbright foundation through a PhD scholar-
ship to DJ; The School of Biology, Georgia Institute of Technology [to IKJ, DJ, ABC
and JW]; An Alfred P. Sloan Research Fellowship in Computational and Evolution-
ary Molecular Biology (BR-4839). The authors would like to acknowledge members
of the Jordan lab for helpful discussions. The authors are also grateful to the EN-
CODE consortium for making their data freely accessible and acknowledge the use
of data generated by the ENCODE institutions and groups below: Broad Institute
and Massachusetts General Hospital-Harvard Medical School/Bernstein Lab (Histone
modifications data). Stanford University/Michael Snyder lab, Yale University/Mark
Gerstein and Sherman Weissman labs, University of Southern California/Peggy Farn-
ham Lab and Harvard University /Kevin Struhl Lab (Transcription factor binding
data) and University of Washington/Sandstrom lab (expression data).
54
CHAPTER 4
COMPOSITE CIS-REGULATORY ELEMENTS WITH
BOTH BOUNDARY AND ENHANCER SEQUENCES IN
THE HUMAN GENOME
4.1 Abstract
It has been suggested that presumably distinct classes of genomic regulatory elements
actually share common sets of features and mechanisms. To evaluate this possibil-
ity, we performed a bioinformatic screen for the existence of composite regulatory
elements in the human genome. We identified numerous co-located boundary and en-
hancer elements from human CD4+ T cells and provide evidence that such composite
regulatory elements facilitate cell-type specific functions related to inflammation and
immune response.
4.2 Introduction
Meticulous regulation of gene expression in eukaryotic genomes is required for the real-
ization of numerous biological processes such as differentiation, development, response
to stimuli and proper immune functioning. Cis- and trans- regulatory elements, to-
gether with epigenetic marks and chromosomal conformation [78, 79], represent some
of the major mechanistic features used to achieve this precise control. Cis-regulatory
elements are non-protein-coding DNA sequences required for proper spatiotemporal
patterns of expression of proximal genes, and they frequently contain binding sites for
transcription factors [58]. Cis-elements are typically small and modular in nature and
function in a manner independent of their location or orientation relative to their tar-
get genes [12]. Their small size and modular nature has enabled detailed functional
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characterization of cis-regulatory elements using reporter constructs in transgenic
animals. Consequently, several types of cis-regulatory elements have been identified
and classified, including transcriptional promoters [46], promoter-tethering elements
[18], enhancers [5], silencers [81], locus control regions (LCRs) [50, 86] and boundary
elements [127], which may include enhancer-blocking insulators [69].
Among all cis-regulatory elements, enhancers exhibit the highest flexibility and
modularity [5, 89] and are also essential drivers of the spatiotemporal specificity of
gene expression [17, 54]. Mechanistically, enhancers can boost gene expression by
recruiting transcription factors, which interact with promoters to recruit RNA poly-
merase II, leading to the initiation of gene transcription [93]. Transcription factors
bound on enhancers can loop over long genomic distances to reach promoters, thereby
giving enhancers the ability to influence the expression of distal genes. In addition to
providing binding sites for transcription factors, enhancers can also function via the
initiation of non-coding RNA transcripts [71], which may facilitate the stabilization of
long range enhancer-promoter interactions via the recruitment of RNA binding factors
[103]. The long-range capacity of enhancers can however be inhibited by boundary
elements, particularly enhancer-blocking insulators [69]. Boundary element insulating
activity protects genes in domains located on the active sides of boundaries against
activating or repressive regulatory effects of both flanking and distant domains. In
this way, enhancer-blocking insulators play a critical role in facilitating the specificity
of interactions between enhancers and genes located in the same chromosomal do-
mains [45, 144]. As such, boundaries and enhancers have hitherto been considered
to be functionally antagonistic, and thus to occupy distinct and separate loci in the
genome. Accordingly, to date no genomic loci have been reported to simultaneously
encode the functional capacities of both enhancers and boundaries.
Nevertheless, it has previously been suggested that boundaries and enhancers
might actually employ a common set of regulatory features and strategies, and more
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generally, that many of the accepted distinctions between classes of regulatory el-
ements may be overstated [44]. Considering this possibility, together with the co-
ordinated regulatory activities of boundaries and enhancers, we sought to evaluate
whether there actually exist co-located composite boundary-enhancer loci in the hu-
man genome. We found that numerous composite boundary-enhancer loci do in fact
exist in the human genome, and we show that these genomic elements have epigenetic
and regulatory features that are distinct from those seen for individual regulatory el-
ements of either class.
4.3 Methods
4.3.1 Boundaries, enhancers and composite elements
We used a set of 2,542 putative boundary elements in CD4+ T cells. These boundaries
were computationally predicted from experimental data using an unbiased algorithm
that relies on the the genomic distributions of chromatin and transcriptional states
[141]. Briefly, the algorithm performs a genome-wide maximal segment assessment of
ChIP-seq data for histone modifications (chromatin state) [7] and RNA Pol II-binding
data (transcriptional state)[6]. It then predicts a genomic locus to be a boundary if 1)
it shows a transition point between facultatively euchromatic (with activating histone
modifications) and heterochromatic (with repressive histone modifications) domains,
and 2) if it shows a transition from sparse to enriched Poll II distribution. We also used
a set of 23,574 enhancers, also in CD4+ T cells. The enhancers were computationally
predicted from experimental data using an algorithm that combines support vector
machines (SVMs) with genetic algorithm optimization (ChromaGenSVM) [37]. The
algorithm automatically selects and uses only the histone marks that best character-
ize active enhancers. It also automatically optimizes the window size of the epigenetic
profiles and other SVM hyperparameters and about 90% of its enhancer predictions
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were supported by atleast one type of experimental evidence[36, 52, 142]. As bound-
ary elements (∼8kb) are larger than enhancers (∼1kb), we searched for loci where any
part of an enhancer overlaps or lies within an annotated boundary region. Boundary
elements were thus divided into two types; the ‘composite’ elements with enhancers
(B+E) and the canonical, non-composite elements without enhancers (B-E). A bi-
nomial test of enrichment was then performed to check for statistical enrichment of
enhancers within boundary elements. For this test, the frequency of enhancers in the
genomic background (number of enhancers divided by genome length) was used to
compute the expected value μ(μ=expected density (7.59e-6 × total length of bound-
aries (2543×8000)=154.4. This was in turn used to compute a Z -score whose P -value





wherex = 265, n = 23574, µ = 154.4, p = µ/n .
4.3.2 Chromatin analysis
Four genome-wide functional genomic datasets generated in CD4+ T cells were an-
alyzed. These included ChIP-seq generated genomic distributions for eight different
histone modifications drawn from thirty eight [7], genomic sites for 95,710 DNase
I hypersensitive sites [13], ChIP-seq generated genomic locations of ∼2 million Pol
II binding sites [7] and ∼8.3 million RNA-seq tags [6]. For all datasets, tags were
re-mapped to boundary regions on the human genome reference sequence (assembly
hg18). For each dataset, tags mapping to 500bp windows spanning a region of 20kb
centered on boundary elements were computed and divided by number of tags in
500bp of genomic background to yield the fold enrichment. The above mapping was
separately performed for regions centered on standalone boundary elements (B-E) and
boundary elements co-locating with enhancers (B+E) (Figure 4.1C,D and C.1C,D).
For each dataset, tests of significance of difference in fold enrichment were done us-
ing paired T-tests between B+E and B-E regions and are shown with corresponding
averages of fold enrichment as bar plots (Figure 4.1C,D and C.1 A,B,C,D). For the
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evaluation of histone modifications, a subset of 8 histone marks (H3K4me1, H3K27ac,
H3K36me3, H3K9ac, H3K4me2, H3K4me3, H4K20me1 and H3K27me3) in the CD4+
cell-line [143] was used (Supplementary figure 4.1A,B). To simplify the assessment, a
combined histone mark fold enrichment index, defined simply as the sum of the fold
enrichments of all individual histone marks was computed and plotted for both B+E
and B-E elements (Figure 4.1C).
4.3.3 Gene expression analysis
32,128 Refseq annotations from the human genome assembly hg18 were downloaded
from the UCSC genome browser [42]. The Refseq annotations were then compiled into
19,539 non-overlapping transcriptional units whose expression levels were determined
as previously described [61] using 44,776 probe sets across 79 human tissues [123].
Genes within 15kb on the open side of boundary elements were then obtained for
both B+E (N=109) and B-E (N=1615) elements. For insight into tissue-specificity,
expression of each gene in CD4+ T cells was compared with its corresponding average
expression in the rest of the 78 tissues, yielding two arrays; one with expression values
in CD4+ T cells and another with the corresponding average expression values in the
rest of the 78 tissues. Averages for both arrays were then computed for B+E and B-E
elements and plotted (Figure 4.1E). Similarly, the difference in gene expression levels
between genes within15kb on the closed chromatin side and genes within 15kb on the
open chromatin side of both B+E and B-E elements was computed in both CD4+ T
cells and the 78 other tissues (Figure 4.1F).Gene expression levels were compared for
CD4+ T cells against the 78 other human tissues using t-tests and z-tests.
4.3.4 Gene set enrichment analysis
Gene set enrichment analysis was performed by evaluating the distribution of func-
tionally coherent sets of genes, as defined by shared Gene Ontology (GO categories
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or presence in the same KEGG pathways, around composite (B+E) versus non-
composite (B-E) boundary elements. The hypergeometric test was used to evaluate
the significance of the enrichment of genes within a defined functional group around
sets of regulatory elements.
4.4 Results and discussion
4.4.1 Composite regulatory element discovery approach
We evaluated the existence of composite mphcis-regulatory elements in the human
genome by searching for genomic loci that are predicted to function simultaneously
as both boundary elements and enhancers (Figure 4.1A).
To do this, we leveraged the availability of large-scale functional genomic data
sets. In particular, application of high-throughput sequencing to chromatin immuno-
precipitation (ChIP-seq) [62] has enabled genome-wide mapping of numerous histone
modifications. Detailed analyses of these datasets has led to the discovery of char-
acteristic patterns of histone modifications for a variety of genomic regulatory fea-
tures including both boundary elements [141] and enhancers [11, 137]. Subsequently,
these regulatory element-specific histone modification profiles have been used to de-
velop computational algorithms that can accurately predict regulatory elements from
genome-wide ChIP-seq data sets. For example, Wang et al. used ChIP-seq data for
histone modifications and RNA Pol II-binding [7] to perform a genome-wide predic-
tion of human chromatin boundaries [141]. Likewise, computational algorithms have
been used to predict enhancers in several human cell lines [37, 54]. For our study, we
analyzed the locations of boundaries and enhancers predicted in this way for human
CD4+ T cells, owing to their vital role in immune function and to the availability of
robust sets of regulatory element prediction datasets for these cells. There are 2,542

















































































































-10 -5 0 5 10
D 
















































































P = < 10-16 
78 tissues 
CD4+ T cell 
E 




















P = < 10-16 






Figure 4.1: Composite regulatory elements and their features in the hu-
man genome.(A) A composite regulatory element possessing both boundary (blue)
and enhancer (red) sequences. (B) Overlap between predicted enhancers (red) and
boundaries (blue). (C, D) Enrichment profiles and average fold enrichments for hi-
stone modifications and Pol2 binding in-and-around boundary elements (blue bars).
(E) Average gene expression for boundary element proximal genes in CD4+ T cells
(grey) and 78 other tissues (white). (F) Average gene expression level differences, be-
tween the open versus closed chromatin sides of boundaries, for CD4+ T cells (grey)
and 78 other tissues (white).
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4.4.2 Enrichment of composite boundary-enhancer elements in the hu-
man genome
We intersected the human genome coordinates of predicted boundary elements with
those of predicted enhancers and found 174 genomic locations with co-located bound-
ary and enhancer annotations (Figure 4.1B and supplementary Table ST5). These
composite regulatory elements represent ∼7% of all boundary elements and 1% of all
enhancers in our dataset. The boundary element predictions used here cover broader
genomic regions (8kb) than the enhancer predictions (1kb); thus, composite boundary
elements may be co-located with multiple enhancers. We compared the observed oc-
currence of composite regulatory elements against their expected level of occurrence,
based on the background genomic frequencies of the individual element classes (see
Methods), in order to ensure that their presence could not be attributed to chance
alone. A binomial test of enrichment revealed enhancers to be significantly enriched
within boundary elements relative to their genomic background frequency (Z=5.39,
P<10-5); there are 72% more enhancers occurring in boundaries than can be expected
by chance alone.
The over-representation of enhancers within predicted boundary regions can be
considered to be surprising in light of the fact that boundaries have until now only
been known to have a presumably antagonistic enhancer-blocking activity [69]. On the
other hand, this finding may reflect the proposition that classes of regulatory elements
typically considered to be distinct actually share sets of features and mechanisms [44].
In any case, the enrichment of enhancers within predicted boundary element regions
suggests an important functional role for these composite regulatory elements. We
explored this possibility via feature analysis of composite cis-regulatory elements.
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4.4.3 Composite boundary-enhancer elements possess unique regulatory
features
The enrichment of enhancers within boundary element regions suggests the possi-
bility that these composite boundary-enhancer regulatory elements represent a func-
tionally distinct combination of their individual regulatory element constituents. If
this indeed proves to be the case, then one may expect to observe distinct regulatory
features, e.g. chromatin and expression profiles, for composite regulatory elements
when compared to those of their individual constituent regulatory elements. To test
this prediction, we compared chromatin and expression profiles from CD4+ T cells
for composite boundary-enhancer regulatory elements (designated as B+E) versus
boundary element regions that lack co-located enhancers (designated as B-E). This
was done using ChIP-seq data for 8 histone modifications [7, 143] to evaluate the
chromatin modification state, DHS site data [13] to evaluate the openness of local
chromatin, as well as RNA Pol II-binding data [7] and RNA-seq [6] data to evaluate
transcriptional states.
For each of these data sets, enrichment plots showing fold en-richment compared
to genomic background levels were computed for 20kb genomic regions centered on
boundaries that are co-located with enhancers (B+E elements) versus boundaries
alone (B-E elements) (Figure 4.1C and D and Supplementary Figure C.1). In addi-
tion, the overall average fold enrichment levels across these regions were determined.
When considered jointly, the 8 histone modifications show significantly higher enrich-
ment for composite B+E regions than seen for B-E regions. These particular histone
modifications were chosen owing to their previously characterized associations with
boundary elements and/or enhancers [37, 54, 55]. In addition, the individual modifi-
cations can be considered to be ‘active’ or ‘repressive’ based on their associations with
the promoters of genes expressed at different levels in CD4+ T cells [37, 54, 55, 143].
With respect to the individual histone modifications, 7 out of 8 histone modifications,
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all of which can be considered to be active modifications, show increased enrichment
around the composite B+E elements (Supplementary Figure C.1B). The sole excep-
tion to this pattern is seen for the repressive modification H3K27me3. Furthermore,
it can be seen that the overall levels of histone modifications are higher for the active
side of the boundaries (boundary start position till +10kb) than for the repressive
side (-10kb till boundary start position), and this effect is also more pronounced for
composite B+E elements than seen for boundary elements only B-E regions (Fig-
ure 4.1C).
Similar patterns of greater B+E enrichment compared to B-E regions can be seen
for Pol II binding data, DHS sites and RNA-seq data (Figure 4.1D and Supplemen-
tary Figure 4.1C and D). The RNA-seq data show a qualitatively distinct pattern
compared to the other data sets with an extremely marked peak close to boundary
element start position. This pattern could indicate that B+E elements most actively
protect gene expression in their most proximal regions and could also point to a spe-
cific role for expression of non-coding RNAs in establishing boundary element and
enhancer activity. Support for both of these possibilities has previously been reported
[91, 141].
Considered together, the results from this analysis suggest the possibility that
composite B+E regulatory elements modulate chromatin structure and facilitate tran-
scriptional changes in a more profound manner than do boundary element only B-E
regions.
4.4.4 Composite boundary-enhancer elements enhance cell type-specific
gene expression
The more distinct chromatin changes and relatively higher tran-scriptional activity
across B+E regulatory elements suggests the possibility that composite regulatory el-
ements may help to facili-tate higher expression levels of proximal genes than bound-
ary only B-E elements. Indeed, since enhancers are known to boost gene expression
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levels, we expect their inclusion into boundary element regions to result in higher
expression of nearby genes. To test this prediction, we compared the relative expres-
sion levels of genes proximal to the active and repressive sides of boundaries for B+E
versus B-E elements. For CD4+ T cell expression levels, B+E elements yield greater
average expression levels on the active sides of boundaries than seen for B-E elements
(Figure 4.1E), and they also create greater expression level differences between the
active versus repressive sides of the elements (Figure 4.1F). Furthermore, this effect
can be seen to be cell type-specific, as these changes are much more pronounced
in the CD4+ T cells where the regulatory elements were predicted compared to a
panel of 78 additional cell types and tissues (Figure 4.1E and F). As seen for the
chromatin environment and boundary-specific expression data discussed previously
(section 3.3), these data underscore the distinct, and more pronounced, regulatory
features associated with composite B+E regulatory elements compared to boundary
only B-E elements.
4.4.5 Potential functional significance for composite boundary-enhancer
elements
Gene set enrichment, based on Gene Ontology (GO) and KEGG pathway annotations,
was used to evaluate the potential functional significance of composite boundary
elements for CD4+ T cells. To do this, the set of genes that lie proximal to B+E
elements were evaluated for evidence of coherent functional signatures that could
be related to T cell-specific or immune-related function. This analysis revealed two
categories of genes that are significantly enriched around B+E elements and encode
proteins with functions that are directly relevant to CD4+ T cell activity; these are
genes involved in the chemokine signaling pathway (GO:007098) and genes related to
the formation of voltage-gated potassium ion channel complexes (GO:0008076).
Chemotaxis, growth, differentiation and apoptosis of inflammatory cells like T-
lymphocytes and eosinophils, are achieved via the chemokine signaling pathway, which
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is largely dependent on the activation of PIK3 kinases [14, 31, 73]. Chemokine signal-
ing pathway genes are significantly enriched around composite B+E elements (Hyper-
geometric test; P=2.6e-6), compared to B-E boundaries (P=0.1.3e-3), and chemokine
signaling pathway genes proximal to composite elements are also expressed at higher
levels, on average, in CD4+ T cells (Figure 4.2A,B and Supplementary Figure C.2).
Chemokine Signaling Pathway Genes 
Symbol Description 
Src Proto-oncogene tyrosine-protein kinase  
ELMO1 Engulfment and cell motility protein 1 
PLCβ 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta 
PIK3 Phosphatidylinositide-3-kinase 
GRB2 Growth factor receptor-bound protein 2 
GRK G protein-coupled receptor kinase 
ROCK Rho-associated, coiled-coil containing protein kinase  
P130CAS Breast cancer anti-estrogen resistance protein  
FAK protein tyrosine kinase 2 
A 
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Figure 4.2: Composite regulatory elements and the chemokine signaling
pathway.(A) Chemokine signaling pathway genes proximal to composite (B+E) reg-
ulatory elements. (B) Enrichment of chemokine signaling pathway genes, and CD4+
T cell expression levels, for composite (B+E) versus canonical (B-E) boundary ele-
ments. (C) Composite (B+E) boundary elements flanking the PIK3 gene and open
chromatin as measured by DHS sites. (D) PIK3-dependent chemokine signaling path-
way. Ligand (purple), membrane receptor (blue).
A specific example of this can be seen for the PIK3 gene, which is functionally
central to the chemokine signaling pathway (Figure 4.2C). PIK3 is expressed at higher
levels in CD4+ T cells (SI=3,463) relative to other human cells/tissues (avg.SI=755),
and indeed there are two B+E composite elements that can be seen to flank the
gene thus helping to maintain a relatively open chromatin environment in this region
(Figure 4.2D).
Potassium transmembrane transport is essential for efficient antigenic activation
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and proliferation of T-cells [25, 26]. Blockage of T-cell potassium channels inhibits
cytokine production and lymphocyte proliferation in vitro and suppresses immune
response in vivo [25, 26, 77], leading to pathogenesis characteristic of autoimmune
diseases like multiple sclerosis [146, 147]. Genes that encode voltage-gated postas-
sim ion channels are significantly enriched around B+E elements (Hypergeometric
test; P=4.5e-7), compared to B-E boundaries (P=0.07), and are also associated with
higher levels of CD4+ T cell-specific expression levels (Supplementary Figure C.3).
In particular, 5 G protein-activated inwardly rectifying potassium channels (GIRKs)
which are responsible for transporting K+ ions into cells are associated with B+E
elements, only 1 is associated with B-E elements, and the only small conductance
calcium-activated potassium channel associated with boundaries (Kca3.1) is B+E
associated (Supplementary Figure C.3C).
4.5 Conclusions
Data reported here support the existence of composite regulatory sequence elements
that encode both boundary and enhancer activities with relevance to T-cell specific
functions. These findings are consistent with the notion there is substantial overlap
between regulatory element function and identity suggesting that regulatory elements
from different classes share mechanistic features and modes of action.
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CHAPTER 5
ON THE PRESENCE AND ROLE OF HUMAN
GENE-BODY DNA METHYLATION
5.1 Abstract
DNA methylation of promoter sequences is a repressive epigenetic mark that down-
regulates gene expression. However, DNA methylation is more prevalent within gene-
bodies than seen for promoters, and gene-body methylation has been observed to be
positively correlated with gene expression levels. This paradox remains unexplained,
and accordingly the role of DNA methylation in gene-bodies is poorly understood.
We addressed the presence and role of human gene-body DNA methylation using a
meta-analysis of human genome-wide methylation, expression and chromatin data
sets. Methylation is associated with transcribed regions as genic sequences have
higher levels of methylation than intergenic or promoter sequences. We also find that
the relationship between gene-body DNA methylation and expression levels is non-
monotonic and bell-shaped. Mid-level expressed genes have the highest levels of gene-
body methylation, whereas the most lowly and highly expressed sets of genes both
have low levels of methylation. While gene-body methylation can be seen to efficiently
repress the initiation of intragenic transcription, the vast majority of methylated sites
within genes are not associated with intragenic promoters. In fact, highly expressed
genes initiate the most intragenic transcription, which is inconsistent with the pre-
viously held notion that gene-body methylation serves to repress spurious intragenic
transcription to allow for efficient transcriptional elongation. These observations lead
us to propose a model to explain the presence of human gene-body methylation. This
model holds that the repression of intragenic transcription by gene-body methylation
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is largely epiphenomenal, and suggests that gene-body methylation levels are predom-
inantly shaped via the accessibility of the DNA to methylating enzyme complexes.
5.2 Introduction
DNA methylation is a crucial epigenetic mark with roles in embryogenesis and differ-
entiation [47], X-inactivation [53], imprinting [85] and repression of viral and repeat
sequences [138]. Changes in patterns of DNA methylation have been implicated in the
pathogenesis of several human diseases [59, 110] including cancer [35]. One long estab-
lished role of DNA methylation in promoter regions is the repression of transcription
[24, 47, 74]. As a result, methylation is largely depleted from the promoter regions of
genes. In contrast, DNA methylation in gene bodies is surprisingly abundant and has
been reported to show a positive correlation with gene expression [2, 4, 56, 83, 88, 108]
even though it can interfere with transcription elongation [90]. The apparent contra-
diction between the activities of DNA methylation in promoters versus gene bodies
has been referred to as the DNA methylation paradox [63]. Here, we address this
paradox in an effort to better understand the presence and role of DNA methylation
in human gene bodies.
Repression of spurious transcription within genes is one possible explanation for
the prevalence of gene-body methylation. Indeed, relatively low average levels of
DNA methylation genome-wide have been taken to suggest that the primary role of
methylation is the repression of spurious transcription rather than the regulation of
promoters per se [10, 63]. More recently, Cap Analysis of Gene Expression (CAGE)
data have confirmed that transcription is very frequently initiated from within genes,
albeit at lower levels than seen for canonical 5’ gene promoters [21, 94]. Thus, it is
reasonable to assume that there may be some need to repress this intragenic tran-
scription. Repression of intragenic promoters by DNA methylation could allow for
more efficient transcriptional elongation, thus accounting for the reported positive
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correlations between gene expression and gene-body methylation levels.
This model predicts a negative correlation between levels of gene-body methy-
lation and the initiation of intragenic transcripts. Such a negative correlation was
recently shown for the case of the human SHANK3 locus where intragenic methyla-
tion regulates intragenic promoter activity [94]. This same study showed that within
intragenic CpG islands genome-wide, there is an overall negative correlation between
transcription initiation and methylation levels. Nevertheless, the extent to which this
relationship holds across gene-bodies is unclear since there are numerous CpG sites
and promoters outside of CpG islands [112].
The notion that gene-body methylation serves to repress intragenic transcription,
thereby allowing for more efficient transcriptional elongation also rests on the re-
ported clear and monotonic positive correlations observed between gene expression
levels and gene-body methylation[4, 56, 83, 88, 108]. However, the relationship be-
tween gene-body methylation and expression levels appears to be more complicated
than previously imagined. In some plants and invertebrates, the relationship is not
monotonic but rather bell shaped with genes expressed at the mid-range levels having
the highest methylation levels [149, 152]. More recently, when a variety human tissue
types were analyzed, some showed a monotonic positive correlation between expres-
sion and gene-body methylation whereas others showed no apparent relationship [2].
Thus, it remains uncertain whether repression of spurious intragenic transcription
best explains the high levels of observed gene-body DNA methylation.
Here, we revisit this issue taking advantage of the recent accumulation of genome-
scale datasets provided by the ENCODE [100, 126] and RIKEN groups. In particular,
the availability of genome-wide human methylation [98], expression [8, 21, 43, 75, 130]
and chromatin datasets [7, 111] provide deep resolution for an interrogation of the
DNA methylation paradox. Meta-analysis of these genome-scale data sets revealed
that 1) the relationship between gene-body DNA methylation and gene expression
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is non-monotonic rather than linear, and 2) while gene-body DNA methylation does
serve to repress spurious transcription, that role does not explain the majority of
methylation in gene-bodies. These results suggest a model whereby gene-body DNA
methylation is chiefly determined by DNA accessibility to methylating enzymes during
transcription, and the repression of intragenic transcription is simply an epiphenom-
enal byproduct of this process. The model accounts for the majority of gene-body
methylation, which cannot be explained by the need to repress spurious transcription
alone. It also explains the observed non-monotonic relationship between gene-body
DNA methylation and gene expression.
5.3 Methods
5.3.1 Human gene loci
Gene annotations for the March 2006 build of the human genome reference sequence
(NCBI build 36.1; UCSC hg18) were taken from the ‘RefSeq Genes’ track of the
UCSC Genome Browser [68, 109]. Individual genes were defined as distinct genomic
loci encompassing all overlapping RefSeq transcripts from the start of the 5’ most exon
to the end of the 3’ most exon. A total of 32,128 RefSeq transcripts were merged into
19,539 genes that represent distinct gene loci.
5.3.2 DNA methylation
Genome-wide DNA methylation data for the GM12878, K562, HepG2, HeLa-S3 and
H1Hesc cell-lines were taken from the ‘ENCODE DNA methylation track’ of the
UCSC Genome Browser (assembly hg19). Methylation data were generated using
the Reduced Representation Bisulfite Sequencing (RRBS) technique [98] and cover
approximately 1.26-1.47 million CpG sites in each of the five cell-lines. The RRBS
methylation data are represented as percent methylation for each covered CpG site,
and herein DNA methylation levels for any locus or genomic region were computed
as the average percentage methylation of all cytosine residues covered therein.
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5.3.3 Gene expression
Exon microarray data for six ENCODE cell-lines (GM12878, K562, HepG2, HeLa-S3,
H1Hesc and HUVEC) were taken from the ‘ENCODE Exon Array’ track of the UCSC
Genome Browser (assembly hg19) [8, 21, 43, 75, 130]. The data were generated using
the Affymetrix Human Exon 1.0 ST GeneChip and analyzed using Affymetrix ExACT
1.2.1 software with samples quantile normalized using the PM-GCBG background
correction and PLIER (probe logarithmic intensity error) summary. Here, the log2
normalized average signal intensity of all exons mapping to an individual gene locus
was taken to represent the overall expression of the gene. This resulted into a final
set of 18,632 genes for which expression data was available in all cell-lines.
Cap Analysis of Gene Expression (CAGE) data [20, 75, 130] were taken from the
‘RIKEN CAGE Loci’ track of the UCSC Genome Browser (assembly hg18). Nucleus
CAGE clusters for GM12878 (1.18 million), K562 (8.86 million) and HepG2 (5.89
million) cell-lines were analyzed here. Discretely located CAGE clusters were taken
as individual proximal promoters (or TSS), and promoter expression levels were com-
puted as the number of CAGE tags in a cluster divided by the length of the cluster.
Intronic CAGE expression levels were calculated in the same way over entire gene
loci.
5.3.4 RNA Polymerase II (Pol2)
RNA Polymerase II (Pol2) binding site ChIP-seq data [7, 40, 62, 131, 151] were taken
from the ‘HAIB TFBS’ track of the UCSC Genome Browser (assembly hg18). The
ChIP-seq reads were re-mapped to the human genome reference sequence (assembly
hg18) in order to rescue individual tags that map to multiple genomic locations as
previously described [140], resulting in approximately 18.78, 6.78, 13.86, 6.78, 20.84,
22.61 and 12.34 million reads in the GM12878, K562, HepG2, HeLa-S3, H1Hesc and
HUVEC cell-lines respectively. For each locus, Pol2 binding density was computed
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as the number of tags mapping on the locus, divided by the length of the locus.
5.3.5 DNaseI Hypersensitive Sites (DHSS)
DNaseI Hypersensitive Site (DHSS) data, generated using the digital analysis of chro-
matin structure (DACS) technique [111, 140], were taken from the ‘UW DNaseI HS’
track of the UCSC Genome Browser (assembly hg18). The DACS sequence reads
were re-mapped to the human genome reference sequence (assembly hg18) in order
to rescue individual tags that map to multiple genomic locations as previously de-
scribed [140], resulting in approximately 30.40, 35.15, 27.32, 44.10, 28.59 and 38.40
million reads in the GM12878, K562, HepG2, HeLa-S3, H1Hesc and HUVEC cell-
lines respectively. For each locus, DHSS density was computed as the number of tags
mapping on the locus divided by the length of the locus.
5.4 Results
5.4.1 Meta-analysis of genome-wide methylation, expression and chro-
matin data sets
The ENCODE project has generated a rich collection of elements that associate with
DNA sequences and have functional consequences for the way the genome is regu-
lated. For this study, we made use of four datasets from the ENCODE project: 1)
DNA methylation data generated by RRBS[98, 111, 140], 2) gene expression data
generated from human exon microarrays[8, 43], 3) RNA polymerase II (Pol2) binding
locations generated by ChIP-Seq [7, 40, 62, 131, 151] and 4) the genomic locations
of DNaseI hypersensitive sites (DHSS) generated by the digital DNaseI technique
[22, 111]. Additionally, we used a fifth dataset from the RIKEN Omics Science cen-
ter made up of CAGE tags that characterize the 5’ ends of full-length transcripts
[75]. All five of these datasets were available for three cell-lines (GM12878, K562 and
HepG2), which together entail the primary focus of the study, and different subsets of
the same five datasets were available in three additional cell-lines (HeLa-S3, H1hESC
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and HUVEC) (Tabletable 6)). These datasets were analyzed in various combinations
across cell-lines in order to interrogate specific aspects of the relationship between
DNA methylation, chromatin and gene expression.
Table 6: Genome-wide expression and chromatin datasets analyzed in
this study.a Specific aspect of gene expression or chromatin being measured.
bExperimental technique or assay used. cENCODE cell types for which the data
are available. dGene Expression Omnibus (GEO) accession numbers for the data.












































































5.4.2 A non-monotonic relationship between gene-body methylation and
human gene expression
The DNA methylation paradox is borne of the fact that in human promoter regions
CpG methylation is negatively correlated to gene expression levels, while in gene
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bodies CpG methylation is apparently positively correlated to gene expression [10].
Furthermore, recent genome-scale analyses of human methylation and gene expression
suggest that this relationship is monotonic, i.e. gene-body methylation levels rise
consistently across increasing intervals of gene expression [4, 83, 88, 108].
We further evaluated this paradoxical relationship using DNA methylation and
gene expression data from ENCODE cell-lines (Table 6). To do this, percent DNA
methylation values in-and-around gene-bodies were compared across five gene expres-
sion level quintiles. Consistent with previous reports in human cell-lines [4, 83], DNA
methylation levels around transcription start sites (TSS) at the 5’ ends of genes show
a clearly negative and monotonic correlation with gene expression levels (Figure 5.1
and Supplementary Figure D.1). The TSS regions of highly expressed genes are rel-
atively depleted for DNA methylation whereas genes expressed at lower levels are
increasingly methylated.
However, the relationship between gene-body methylation and expression levels
is different from what has been described before; gene-body methylation levels show
a bell-shaped, rather than monotonic, relationship with gene expression levels (Fig-
ure 5.1 and Supplementary Figure 5.1). Generally, mid-level expressed genes in the
3rd and 4th quintiles have the highest DNA methylation percentages while those in
the 2nd and 5th quintiles show medium DNA methylation percentages and those
in the 1st quintile show the lowest DNA methylation percentages. A similar bell-
shaped relationship between gene-body methylation and expression levels has been
observed previously in plants (Arabidopsis thaliana and Oryza sativa) and inverte-
brates (Ciona intestinalis and Nematostella vectensis) [149, 152]. Human gene-body
methylation levels measured here are about the same as those of those of the TTS
regions but higher than those seen for both the regions surrounding TSS and the
associated intergenic regions (Figure 5.1 and Supplementary Figure D.1).
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Figure 5.1: DNA methylation levels around the TSS, gene-body and TTS
across five gene expression level bins (A) Average percentage methylation lev-
els of 100bp windows spanning the TSS, gene-body and TTS, showing 3kb and 5kb
upstream and downstream of TSS respectively and 5kb and 3kb upstream and down-
stream of TTS respectively. (B) Overall average (± standard error) percentage methy-
lation levels for TTS, gene-body and TTS.
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gene-body methylation and gene expression observed here, we sought to evaluate this
pattern at a higher level of resolution. To do this, human genes were divided into
100 expression level bins, and then methylation and gene expression levels were re-
gressed across these intervals. This analysis further revealed a clearly non-monotonic
and bell-shaped relationship between gene-body methylation and gene expression in
all five human cell lines for which methylation data was available (Figure 5.2 and
Supplementary Figure 5.2). The mid-level expressed genes showed the highest DNA
methylation levels while both the lowest and highest expressed genes had markedly
lower DNA methylation levels.
DNA methylation levels have also been found to be related to gene length [150].
We thus sought to check if the bell-shaped relationship we found between gene-body
methylation and gene expression is not infact a reflection of the relationship between
DNA methylation and gene length. To do this, we checked if the bell-shaped relation-
ship would still be present for sets of genes with widely differing lengths. We found
a similar bell-shaped non-montonic relationship between gene-body methylation and
gene expression for both the 20% shortest and 20% longest genes suggesting that the
relationship is independent of gene length (Supplementary Figure D.3).
5.4.3 Gene-body methylation represses the initiation of intragenic tran-
scription
DNA methylation was originally thought to serve primarily to repress spurious tran-
scription [10], and gene-body methylation has been shown to repress the activity of
intragenic promoters [94]. Thus, it may be the case that gene-body methylation serves
to repress spurious transcription from intragenic promoters, thereby allowing for more
efficient transcriptional elongation. This kind of repressive role for DNA methylation
could explain the relative abundance of DNA methylation within gene-bodies and its
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Figure 5.2: A non-monotonic relationship between gene-body DNA methy-
lation and gene expression. Overall percentage methylation of gene-bodies (re-
gions starting at 1kb downstream of the TSS and ending at 1kb upstream of the TTS
of genes) is regressed against gene expression for (A) GM12878 (B) K562 and (C)
HepG2. Genes are grouped into 100 gene expression bins.
To evaluate this possibility here, we used CAGE data to analyze the relation-
ship between gene-body methylation and the repression of intragenic transcription.
Intronic CAGE clusters mark intragenic promoters and the levels of transcriptional
initiation from these intragenic promoters are characterized by the number of CAGE
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tags per intronic cluster [21, 94]. We mapped intragenic promoters across three EN-
CODE cell-lines using CAGE, and then DNA methylation levels at these intragenic
promoters were regressed against the promoter activity levels measured by CAGE
tag density. For all three cell-lines, this analysis revealed significantly negative cor-
relations between the DNA methylation levels of intronic promoters and their cor-
responding transcriptional initiation levels (Figure 5.3A). These data are consistent
with the repression of intragenic promoters by DNA methylation. Indeed, a similar
analysis of canonical TSS from the 5’ ends of the genes, where the repressive role of
DNA methylation is well known, yields qualitatively identical results (Figure 5.3B).
5.4.4 Gene-body methylation, transcription and open chromatin
TheResults from the previous section indicate that gene-body methylation can re-
press intragenic transcription. Accordingly, if the primary role of gene-body methy-
lation is to repress spurious intragenic transcription, then there should be more DNA
methylation at intronic promoters than at intronic sites that do not initiate tran-
scription. However, we find the vast majority of gene-body DNA methylation maps
to sites that do not initiate transcription (Figure 5.4A). Presumably, this majority
fraction of intronic DNA methylation does not serve to repress transcription. Fur-
thermore, levels of gene-body methylation are highly positively correlated for these
two classes of intronic sites: transcriptional initation sites and non-transcriptional
initiation sites (Figure 5.4B-D). In other words, there is no particular enrichment of
DNA methylation at intragenic promoters compared to their surrounding genic envi-
ronment. Rather, DNA methylation levels are consistent across introns of individual
gene-bodies and appear to be largely determined by something other than the need
to repress intragenic transcription.
These results instead suggest that gene-body DNA methylation is deposited onto
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Figure 5.3: Relationship between DNA methylation and promoter activity
levels. Percent DNA methylation levels are regressed against CAGE expression levels
(i.e. promoter activity) for (A) intronic and (B) canonical 5’ gene promoters. Genes
are grouped into 100 gene expression bins. Pearson correlation coefficient values (r)
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r = 0.95 
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P = 5.2e-63 
Figure 5.4: Comparison of length and DNA methylation attributes of in-
tronic promoters and intronic sites without transcription initiation. (A)
Percentage of intronic length occupied by transcription initiation sites (black) and
versus sites without transcription initiation (grey). Percent DNA methylation lev-
els for transcription initiation sites are regressed against methylation levels for non-
transcription initiation sites for (B) GM12878, (C) K562 and (D) HepG2 cell-lines.
Genes are grouped into 100 methylation level bins. Pearson correlation coefficient
values (r) along with their significance values (P) are shown for each regression.
DNA methylated sites are involved in the silencing of spurious intragenic transcrip-
tion. The relationship we observe between gene-body DNA methylation and gene
expression (Figure 5.2) suggests that the transcriptional elongation process, together
with its associated open chromatin, might account for much of gene-body methylation.
If gene-body methylation is linked to transcriptional elongation, then transcribed re-

















Figure 5.5: Comparison between genic and intergenic average (± standard
error) DNA methylation levels in GM12878, K562 and HepG2 cell-lines.
In fact, we observe that human genic regions do have substantially higher levels of
DNA methylation than seen for intergenic regions (Figure 5.5 and Supplementary Fig-
ure D.4). In addition, a similar elevation of DNA methylation levels for transcribed
genic regions has been reported in a number of other species [124, 149].
DNA methylation is clearly associated with the presence of transcribed gene re-
gions, and levels of transcription for these gene regions are expected to be associated
with a distinct chromatin environment including high occupancy levels of Pol2 and the
presence of demonstrably open chromatin. To test this, we regressed gene expression
levels against Pol2 occupancy levels and the extent of open chromatin measured by
the presence of DNaseI hypersensitive sites (DHSS). Both Pol2 occupancy levels and
the extent of open chromatin are in fact highly positively correlated with gene expres-
sion across all six ENCODE cell-lines evaluated here (Figure 5.6 and Supplementary
Figure 5.5).
When considered together with the data showing that gene-body methylation
accumulates independent of the need to repress spurious intragenic transcription
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Figure 5.6: Relationship between chromatin environment and gene expres-
sion levels (A) Pol2 occupancy and (B) density of DHSS sites are regressed against
gene expression. Genes are grouped into 100 gene expression bins. Pearson correla-
tion coefficient values (r) along with their significance values (P) are shown for each
regression.
an important prerequisite for the deposition of gene-body methylation. However, the
relationship between gene-body methylation and open chromatin is non-monotonic,
suggesting that the extent of open chromatin alone does not determine gene-body
methylation levels. In the discussion section, we propose a specific model to explain
the presence of gene-body DNA methylation that accounts for this complexity.
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5.5 discussion
DNA methylation is a well known repressive chromatin mark when associated with
promoter regions. However, DNA methylation is far more prevalent in gene-bodies
than in promoters and the role of gene-body methylation is still not clearly under-
stood. In this study, we performed a meta-analysis of genome-wide methylation,
expression and chromatin data sets in an attempt to better understand the presence
and role of gene-body DNA methylation.
We show that levels of DNA methylation are more clearly related to the presence
of transcribed regions than to the impetus to repress spurious intragenic transcription.
However, the quantitative relationship between gene-body methylation and expres-
sion levels in non-monotonic and bell-shaped. On the other hand, the relationships
between gene expression levels and Pol2 occupancy along with open chromatin are
positive and monotonic. Considered together, these results link gene-body methyla-
tion to transcription and open chromatin, albeit in a complex and non-linear way.
Here, we propose a specific model to explain the presence of gene-body DNA methy-
lation in light of these results.
Our model rests on the notion that the deposition of DNA methylation is mech-
anistically facilitated, to some extent, by open and actively transcribed chromatin.
In support of this contention, a biochemical study demonstrated that DNA methyl-
transferase 1 (DNMT1) interacts with Pol2 by binding the C-terminal repeat domain
of Pol2 [22]. It has also been shown that the catalytic domain of DNMT1 needs to
directly bind to DNA and to transit along the DNA molecule in order to function
[41, 134]. Nevertheless, the bell-shaped relationship between gene-body methylation
and expression levels indicates that open and actively transcribed chromatin does
not completely determine gene-body methylation. On the contrary, there appears
to be some trade-off between the openness of the chromatin and the levels of DNA
methylation, and we also try to account for this in our model.
84
The model explaining levels of gene-body methylation is illustrated in Figure 5.7
and can be summarized as follows. The extent of nucleosome packaging seen for un-
expressed and compact chromatin would not allow for access to the DNA by DNMT1,
effectively blocking DNA methylation. At low levels of transcription, transiting Pol2
complexes disrupt nucleosome packaging and open up the chromatin thereby exposing
CpG sites for methylation. Therefore, levels of gene-body methylation will increase
with increasing levels of expression at the low end of the expression spectrum. How-
ever, as genes become increasingly highly expressed, the density of transiting Pol2
becomes so high as to begin to interfere with the processivity of DNMT1 along DNA.
This leads to a progressive reduction of gene-body methylation levels with increasing
expression levels at the high end of the expression spectrum. Therefore, the most
lowly and the most highly expressed genes will have the lowest levels of methyla-
tion, whereas genes expressed at intermediate levels will have the highest gene-body
methylation, as seen here for humans and elsewhere for other species [149, 152].
While we find this model to be mechanistically compelling for the reasons de-
scribed above, it does not directly address the demonstrated role of gene-body DNA
methylation in repressing spurious intragenic transcription. To investigate this fur-
ther, we re-evaluated the intronic CAGE data in light of the non-monotonic relation-
ship between gene expression and gene-body methylation levels. Regressing intronic
CAGE levels against gene expression data and comparing this relationship to that seen
for methylation and expression reveals a coincident inflection point between the two
curves where methylation levels fall off to such an extent as to begin to allow for the
initiation of transcription from intragenic promoters (Figure 5.8). This observation
unites the DNA accessibility model for gene-body methylation that we propose with
the role of methylation in repressing intragenic transcription. However, the juxtapo-
sition of these two phenomena can also be taken to suggest the intriguing possibility
that the observed repression of intragenic transcription by methylation is simply a
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     across gene bodies 
2. At low levels of expression, 
     dense nucleosome packaging 
     prevents methylation by 
     blocking DNMTs access 
     to the DNA 
4. At high levels of expression, 
     Pol2 density interferes with 
     DNA access and processivity 
     of DNMTs  
3. At mid levels of expression, 
     transiting Pol2 disrupts  
     chromatin exposing CpG  
     sites to methylation by 
     DNMTs 
Figure 5.7: Model showing how interactions between chromatin openness
and Pol2 density specify gene-body DNA methylation. DNA (black string),
CpG sites (potential methylation sites - red), methyl groups (purple), nucleosomes
(blue), polymerases (brown) and DNMT1(green).
by-product of relative accessibility levels to the DNA by methylating enzymes.
The relationship between gene expression levels, Pol2 density and initiation of
transcription from intragenic promoters also serves to distinguish our observations
and model from what has previously been proposed for A. thaliana [152]. The A.
thaliana model also attempted to explain an observed bell-shaped distribution for
gene-body methylation with respect to expression, and the model held that gene-body
methylation was facilitated by the transcription of siRNAs from intragenic promoters.
Transcription of these intragenic siRNAs was thought to be facilitated by the progres-
sive opening of the chromatin from low-to-mid levels of expression, and then these
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Figure 5.8: Decreasing levels of gene body methylation, starting from mid-
levels of gene expression are correlated with increasing levels of intronic
expression. Highly expressed genes are represented by pink background while lowly
expressed genes are represented by light blue background. (A) Gene expression levels
are regressed against percent gene-body methylation (top curve) and levels of in-
tronic expression (bottom curve). (B) Comparison of average intronic transcription
(open bars) and average percentage methylation (grey bars) between lowly and highly
expressed genes.
machinery in situ. However, at high levels of transcription, Pol2 density was thought
to be too great to allow for the initiation of intragenic transcription thus accounting
for the low levels of methylation for highly expressed genes. On the contrary, here
we observe that the initiation of transcription from intragenic promoters increases
steadily with increasing expression and Pol2 occupancy levels peaking among highly
expressed genes that also show low levels of gene-body methylation (Figure 5.8).
It should also be noted that our observations on the relationship between expres-
sion level and gene-body methylation, at the high end of expression, are consistent
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with previous results showing that gene-body methylation interferes with transcrip-
tional elongation [90]. Thus, the patterns observed here may also point to incompati-
bility and selection against high levels of gene-body methylation for highly expressed
genes.
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In summation, this thesis is constituted by four chapters, which try to address knowl-
edge gaps and longstanding questions at the intersection of three interrelated areas
of human genome regulation; 1) repetitive DNA evaluated from the perspective of
transposable elements, 2) epigenetics as evaluated from the standpoint of gene-body
DNA methylation and 3) cis-regulation, which is assessed with regard to the nature
and diversity of cis-regulatory elements. CHAPTER 2 establishes the relationship
between the transposable element environment of human genes and their expression,
and evaluates both the ‘selection’ and the ‘genomic design’ hypothesis. Following
the discovery in chapter 2 that a specific family of transposable elements (MIRs) is
associated with tissue-specific gene expression, CHAPTER 3 evaluates the possible
mechanism behind that relationship, and addresses its associated functional implica-
tions. CHAPTER 4 examines human genome regulation by assessing the nature and
diversity of cis-regulatory elements with respect to boundary elements and enhancers.
It clarifies a recent postulation that distinctions between certain classes of elements
are in some cases not definitive. Finally, CHAPTER 5 investigates the longstanding
DNA methylation paradox. It addresses important aspects of that paradox, particu-
larly, the relationship between gene-body DNA methylation and gene expression, and
the role and dynamics of gene-body DNA methylation. Various studies have found
transposable elements to influence gene expression and phenotype [39, 65, 96]. These
discoveries have negated prior assertions that transposable elements are merely ‘junk
DNA’ with no important effects on genome regulation [32, 102]. CHAPTER 2 builds
on that body of knowledge, revealing that apart from the exaptation of individual
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TEs for specific functions [15, 16], the TE environment of human genes itself is related
to gene expression in very TE class-specific ways. It quantifies the apparent effects of
the density of various classes and families of TEs in and around genes on gene expres-
sion. Further, using multiple regression models, CHAPTER 2 achieves the separation
of the effects of TEs from the effects of gene length on gene expression. That analysis
shades light on the distinct effects of these two interrelated aspects of gene architec-
ture, finding TEs to be more important than gene length for gene expression. That
separation is then used to assess the two long-standing hypotheses that have been
used to explain the shortness of highly expressed genes i.e. the selection hypothesis
[23] and the genomic design hypothesis [135], finding the selection hypothesis to be
more plausible. Finally CHAPTER 2 shows a specific family of TEs (MIRs) to be the
only one positively related to tissue-specific gene expression. The discovery in CHAP-
TER 2 that MIRs are the only tissue-specific TEs is further evaluated in CHAPTER
3 in an effort to try and understand the mechanism behind that relationship. Here,
the specific loci at which MIRs exercise their effects on tissue specific gene expression
genome-wide are established to be enhancers. CHAPTER 3 reveals MIRs to be highly
concentrated in enhancers, which are the genomic elements that have been previously
linked to tissue-specific expression [54, 55]. The prevalence of TFBSs within these
enhancer associated MIRs is surveyed and found to be significantly higher than their
frequencies in the genomic background. This finding suggests the donation of TF-
BSs to be one of the reasons for the extensive exaptation of MIRs into enhancers
and their subsequent long standing conservation in the human genome and their ex-
tensive presence in mammalian genomes. Using the K562 cell-line as the example,
this chapter shows the densities of MIR-enhancers around genes to be significantly
related to their expression levels. Infact further analysis reveals that association to
be functionally relevant, as exemplified by the enrichment of MIR-enhancer associ-
ated genes in various biological processes related to erythropoiesis which is a function
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largely specific to the K562 cell-line. It has been recently postulated that distinctions
between various classes of cis-regulatory elements may not be as definitive as pre-
viously thought. CHAPTER 4 examines this possibility by using recently predicted
genome-wide boundary elements and enhancers to re-evaluate the nature and diver-
sity of cis-regulatory elements. A genome-wide bioinformatics scan of the two types
of elements establishes the existence of 174 composite cis-regulatory elements. These
are genomic loci that simultaneously encode both boundary and enhancer functions
and at which the two elements are physically co-located. Additionally, both the epige-
netic environment (DNAse hypersensitive sites, Pol2 and histone modifications) and
gene expression parameters (expression level and tissue-specificity) of genes associated
with these elements are revealed to be significantly higher than for the non-composite
locations. This distinct effect of composite cis-regulatory elements is also reflected
at the functional level, where upon evidence is elicited that in CD4+ T cells, these
elements potentially facilitate cell-type specific functions related to inflammation and
immune response. The DNA methylation paradox [63] has for long been a perfect
example of our inadequate understanding of the dynamics underlying the effects of
epigenetics in general and DNA-methylation in particular on the genome regulation
landscape. CHAPTER 5 addresses important aspects of the DNA methylation para-
dox, particularly the relationship between gene-body DNA methylation and gene
expression, and the role and dynamics of gene-body DNA methylation. Using Chip-
seq datasets that have recently become available owing to the recent advancement of
sequencing technologies, this chapter re-evaluated this longstanding paradox. First,
the results here found that contrary to previous reports [2, 4, 56, 83, 88, 108], the
relationship between gene-body DNA methylation and gene expression is not linear
but non-monotonic and bell-shaped. Secondly, while confirming previous findings
that gene-body DNA methylation represses aberrant intragenic transcription [10, 94],
chapter 5 finds evidence that this role is only epiphenomenal and not the reason for
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presence of DNA methylation in gene-bodies. This finding is based on a proposed
model derived from a collation of the various analyses in the chapter which points to
the deposition of gene-body DNA methylation to be regulated by dynamics related
to the access of DNA to methylating complexes rather than the evolutionary need
to repress intragenic transcription initiation. In total therefore, this thesis provides
several new insights in the nature, mechanisms and effects of repetitive DNA, DNA





SUPPLEMENTARY INFORMATION FOR CHAPTER 2
Table ST1: TEs classified based on whether they are long (>400bp) or short
(<400bp). Almost all SINES are short, but there are significant numbers of the
other TE classes or families that are long. Nevertheless an overwhelming percentage
of TEs in genes are short.
ALU MIR L1 L2 DNA LTR
All TEs 237018 130293 104129 83702 90399 43304
TEs < 400bp 237012 130292 71031 72614 83825 30591
























Figure A.1: Demarcating transcriptional units on the genome and Mapping
TEs to TUs.(A) Transcriptional units were mapped as genomic regions encompass-
ing all overlapping transcripts, from the start of the 5’ most exon to the end of the
3’ most exon. (B) TE fractions in TUs were computed for each TE family as the
number of base pairs occupied by a TE as a fraction of all base pairs in the TU. The
figure shows the average TE fraction of each TE family in all the TUs.
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Figure A.2: The relationship between TE fractions of genes and GL. Correla-
tions of TE levels and gene length for all TE types. Each data point represents a bin
containing 156 genes. The significant p-value of correlation by Bonferroni correction
is 8.3× 10-3
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Figure A.3: Relatedness of tissues in which MIR-rich genes are maximally
expressed. Chi-square analysis showing enrichment of certain related tissues (mostly
blood tissues [blue]) and depletion of certain other related tissues (mostly nervous
tissues [purple]) among tissues hosting the maximum expression of MIR-rich genes.
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APPENDIX B
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Figure B.1: MIRs are highly concentrated within enhancers.(A) Heat maps
showing the average MIR densities of 100 equal bins of genes in the HeLa cell-line.
Upper bars show average MIR density in the genic enhancers of each bin, while lower
bars show average MIR density in the corresponding non-enhancer sequences of the
genes in the same bin. Bins are arranged left to right in decreasing MIR densities
in genes. (B) Bar graph showing the density of MIRs in the core 200bp of genic
enhancers (white bars) versus the corresponding non-enhancer sequences of the genes
(grey bars). (C) Fold enrichment plots of MIRs in and around all genic enhancers
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Figure B.2: The chromatin environment of MIR-enhancers and enhancer-
MIRs is similar to that of canonical enhancers. Fold enrichment of histone
modifications within 20kb regions centered on different categories of elements (A)
Canonical enhancers, (B) MIR-enhancers, (C) Enhancer-MIRs in HeLa cell-lines and
(D) Enhancer-MIRs in K562 cell-lines
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Table ST2: Enrichment statistics of enhancer-MIR associated genes in gene sets of
biological functions linked to erythropoiesis. Enrichment was computed using the










Erythropoiesis (erythroid differentiation) 73 44 2.0 x 10-14 13.7 
Interphase of mitotic cell cycle 62 32 1.1 x 10-8 12.7 
Hemopoietic or lymphoid organ development 76 43 6.5 x 10-13 12.5 
Myeloid cell differentiation  37 22 8.0 x 10-8 12.2 
Immune system development 80 46 4.7 x 10-14 8.0 
Homeostasis of a number of cells 20 12 6.5 x 10-5 7.1 
Hemopoiesis 74 43 1.9 x 10-13 4.2 
Regulation of myeloid cell differentiation 19 10 1.0 x 10-3 3 
Negative regulation of myeloid cell development 10 4 8.2 x 10-2 1.1 
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Figure B.3: Histone modifications patterns around enhancer-MIRs and
MIR-enhancers are congruent to that around canonical enhancers.(A) Con-
gruence of histone modifications fold enrichment between MIR categories and canon-
ical enhancers. Datapoints represent the histone modification fold enrichments for
windows equally distant from the centers of the respective MIR categories in each
plot. (B) Rank order of correlations of modifications fold enrichments between MIR
categories and canonical enhancers weighted by slope.
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Table ST3: The genes are differentially expressed at the various stages of erythro-
poiesis. Genes with the same color are co-expressed and correspond to the color codes
in Figure 5.
Gene Symbols Gene Descriptions 
CTSH Cathepsin H 
INSIG1 Insulin induced gene 1 
ITGB5 Integrin, beta 5 
NFYA Nuclear transcription factor Y, alpha 
PTP4A3 Protein tyrosine phosphatase type IVA, member 3 
PTPN7 Protein tyrosine phosphatase, non-receptor type 7 
APOC1 Apolipoprotein C-I 
BIRC5 Baculoviral IAP repeat-containing protein 5 
GFI1B Growth factor independent 1B transcription repressor 
ICAM3 Intercellular adhesion molecule 3 
LMO2 LIM domain only 2 (rhombotin-like 1) 
MT2A Metallothionein 2A 
MYB MYB v-myb myeloblastosis viral oncogene homolog 
SOCS2 Suppressor of cytokine signaling 2 
ADAM10 A disintegrin and metalloproteinase domain-containing protein 10 
DHX9 DEAD/H box polypeptide 9 
GTF2I General transcription factor II, i 
SLC2A14 Solute carrier family 2 (facilitated glucose transporter), member 14 
SLC43A3 Solute carrier family 43, member 3 
GYPA Glycophorin A (MNS blood group) 
KLF1 Kruppel-like factor 1 (erythroid) 
NCOA1 Nuclear receptor coactivator 1 
NPL N-acetylneuraminate pyruvate lyase (dihydrodipicolinate synthase) 
SLC27A2 Solute carrier family 27 (fatty acid transporter), member 2 
CREM cAMP responsive element modulator 
DDIT4 DNA-damage-inducible transcript 4 
HSPA5 Heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa 
IER3 Immediate early response 3 
IER5 Immediate early response 5 
AKR1C1 Aldo-keto reductase family 1, member C1 
ATF5 Activating transcription factor 5 
HBA1 Hemoglobin, alpha 1 
IL8 Interleukin 8 
RTN4 Reticulon 4 
UCP2 Uncoupling protein 2 (mitochondrial, proton carrier) 
CTSL1 Cathepsin L1 
HSPA1B Heat shock 70kDa protein 1B 
PIM1 Pim-1 oncogene 
DNAJB4 DnaJ (Hsp40) homolog, subfamily B, member 4 
HBZ Hemoglobin, zeta 
MAFG MAFG v-maf musculoaponeurotic fibrosarcoma oncogene homolog G 
OSGIN1 Oxidative stress induced growth inhibitor 1 
TXNRD1 Thioredoxin reductase 1 
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Figure B.4: Presence and activity of transcription factor binding sites in
enhancer-MIRs.(A) Number of TFBSs in enhancer-MIRs (Blue) and random ge-
nomic sequences (Grey). (B) Log2 fold enrichment of TFs bound to enhancer-MIRs
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Figure B.5: Effect of enhancer-MIRs on gene expression and tissue speci-
ficity in the HeLa cell-line.(A) Relationship between density of enhancer-MIRs
and gene expression levels. (B) Relationship between density of enhancer-MIRs and
tissue-specificity of gene expression across 6 ENCODE cell-lines. (C). Relationship
between density of enhancer-MIRs and tissue-specificity of gene expression across 79
tissues from the Norvatis gene expression atlas. Pearson correlation coefficient values
(r) along with their significance values (p) are shown for all pairwise regressions.
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Lists of genomic locations of core loci of MIR-enhancers
K562 HeLa
Chromosome Position Chromosome Position
chr1 160608516 chr1 107290131
chr1 165466216 chr1 107953231
chr1 171791116 chr1 108014231
chr1 179364016 chr1 109552531
chr1 179388116 chr1 110118731
chr1 180141416 chr1 110137231
chr1 194136416 chr1 113486231
chr1 200119916 chr1 115560731
chr1 201524216 chr1 115771531
chr1 201875316 chr1 117909031
chr1 203536216 chr1 118442831
chr1 203913516 chr1 118711031
chr1 203971416 chr1 143875763
chr1 204803778 chr1 143931563
chr1 204815678 chr1 150184601
chr1 204911678 chr1 154365201
chr1 206114678 chr1 154382601
chr1 209574978 chr1 155384501
chr1 219207678 chr1 156265301
chr1 221417894 chr1 156274001
chr1 222647638 chr1 158023201
chr1 227552238 chr1 161342216
chr1 229404138 chr1 162133916
chr1 232724438 chr1 162848716
chr1 232731038 chr1 163781016
chr1 232785838 chr1 166838616
chr1 234584232 chr1 166843716
chr1 234781332 chr1 170490216
chr1 235038232 chr1 171426616
chr1 235143332 chr1 173415616
chr1 242572232 chr1 174081816
chr1 244022232 chr1 175326116
chr1 244235332 chr1 178822316
chr1 244299032 chr1 181306016
chr2 9738303 chr1 181507316
chr2 11775303 chr1 184952616
chr2 11988803 chr1 185890516
chr2 12025303 chr1 190713116
chr2 12167103 chr1 190759816
chr2 12226403 chr1 191893216
chr2 16482903 chr1 191916616
chr2 17624403 chr1 195366916
chr2 20663003 chr1 197969616
chr2 21306003 chr1 199711916
chr2 26089403 chr1 200119816
chr2 26093903 chr1 200342816
chr2 27091603 chr1 201929816
chr2 28418803 chr1 203522316
chr2 28443303 chr1 203714016
chr2 28786803 chr1 204161416
chr2 30530303 chr1 204186516
chr2 37763203 chr1 205482378
chr2 38623503 chr1 206373778
chr2 42984903 chr1 207191878
chr2 46351203 chr1 207548878
chr2 46422503 chr1 207589578
chr2 46631703 chr1 208532978
chr2 47063203 chr1 209832078
chr2 48347903 chr1 209883078
chr2 48405803 chr1 210737878
chr2 48514403 chr1 212695478
chr2 60838703 chr1 212765778
chr2 62297903 chr1 215425278
chr2 65198703 chr1 215515378
chr2 65431603 chr1 216621578
chr2 65476803 chr1 217114778
chr2 65569303 chr1 221272278
chr2 68465503 chr1 221664494
chr2 68848803 chr1 225017238
chr2 69880703 chr1 225033138
chr2 74268403 chr1 230003238
chr2 80374903 chr1 231853038
chr2 85069303 chr1 232724438
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chr2 86032203 chr1 235242332
chr2 86035003 chr1 238628732
chr2 87684103 chr2 1608760
chr2 88179403 chr2 6783703
chr2 96086803 chr2 8363603
chr2 96372003 chr2 10383003
chr2 96859803 chr2 10385003
chr2 101288664 chr2 10572203
chr2 102319264 chr2 11444903
chr2 102403564 chr2 11590903
chr2 102616164 chr2 12064003
chr2 110658064 chr2 12514703
chr2 112960890 chr2 12613303
chr2 113507690 chr2 12772903
chr2 113654590 chr2 15789203
chr2 126749490 chr2 16688903
chr2 128340390 chr2 17624403
chr2 134693988 chr2 18597203
chr2 144970788 chr2 20571203
chr2 145069488 chr2 20642003
chr2 149127888 chr2 20682903
chr2 158420488 chr2 23277003
chr2 166921189 chr2 23289703
chr2 168512089 chr2 25568403
chr2 173142089 chr2 26056203
chr2 178219389 chr2 26798903
chr2 178330189 chr2 26800903
chr2 183602989 chr2 27998103
chr2 198489289 chr2 28172403
chr2 202910889 chr2 28525503
chr2 202960289 chr2 28688803
chr2 216015289 chr2 29182503
chr2 217935089 chr2 29520403
chr2 218906589 chr2 30370303
chr2 220026389 chr2 36508903
chr2 220043189 chr2 36781603
chr2 223630389 chr2 39650903
chr2 231292289 chr2 41402303
chr2 233904289 chr2 45107103
chr2 236032689 chr2 46786903
chr2 236070589 chr2 46800803
chr2 239866133 chr2 46883703
chr2 241946333 chr2 47035703
chr3 4368950 chr2 50638203
chr3 4437750 chr2 54654803
chr3 4563050 chr2 55093303
chr3 5011150 chr2 56040703
chr3 5024250 chr2 58643303
chr3 5034450 chr2 59317703
chr3 12533550 chr2 65056703
chr3 12773550 chr2 66318203
chr3 14293950 chr2 67377203
chr3 14407550 chr2 67605803
chr3 14447450 chr2 67920603
chr3 14474350 chr2 69234503
chr3 15134450 chr2 74068403
chr3 23966750 chr2 74648103
chr3 24275450 chr2 75889803
chr3 24333750 chr2 84110503
chr3 33919950 chr2 84183503
chr3 33931750 chr2 85072803
chr3 38741350 chr2 85518703
chr3 44458550 chr2 85850803
chr3 47283250 chr2 91150803
chr3 47336650 chr2 95340303
chr3 47478050 chr2 95463403
chr3 52659750 chr2 95672203
chr3 58068250 chr2 96403703
chr3 63898550 chr2 96783403
chr3 65594750 chr2 98789364
chr3 67781350 chr2 101353264
chr3 69127750 chr2 102111364
chr3 69877550 chr2 113804390
chr3 69879350 chr2 115888290
chr3 69917250 chr2 118535890
chr3 71048350 chr2 118861790
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chr3 72225350 chr2 121245490
chr3 72442250 chr2 125448490
chr3 72464550 chr2 126186490
chr3 73124050 chr2 127574590
chr3 77210450 chr2 133248888
chr3 120758950 chr2 133722588
chr3 128125342 chr2 134360588
chr3 129546242 chr2 139841188
chr3 130218342 chr2 144205188
chr3 130227542 chr2 145020088
chr3 130647342 chr2 145134288
chr3 130802042 chr2 150310888
chr3 130858942 chr2 150663088
chr3 131586142 chr2 153072288
chr3 131914542 chr2 159410289
chr3 131990842 chr2 159612689
chr3 140337642 chr2 160674989
chr3 140462842 chr2 160785889
chr3 143828742 chr2 161087689
chr3 151369742 chr2 164317589
chr3 151577642 chr2 166174789
chr3 151928742 chr2 173266289
chr3 151934842 chr2 173622089
chr3 156226842 chr2 174162689
chr3 169288342 chr2 177818489
chr3 171332842 chr2 177846589
chr3 172009142 chr2 181296289
chr3 173713342 chr2 182832489
chr3 174058142 chr2 182897089
chr3 178537442 chr2 192549589
chr3 180537142 chr2 195981989
chr3 180638842 chr2 197681289
chr3 182119342 chr2 200703589
chr3 184754842 chr2 200890189
chr3 186375442 chr2 204156189
chr3 188197742 chr2 210449189
chr3 195290542 chr2 210511089
chr3 195402242 chr2 216103089
chr3 195446542 chr2 217126289
chr3 195448142 chr2 217169789
chr3 195456142 chr2 223326889
chr3 197303137 chr2 223846889
chr3 1.98E+08 chr2 224434389
chr3 1.98E+08 chr2 224817789
chr3 198022300 chr2 225483389
chr4 2839342 chr2 226044589
chr4 25941779 chr2 226689589
chr4 26397779 chr2 226829789
chr4 37921079 chr2 228033389
chr4 38536279 chr2 229855789
chr4 39648679 chr2 230061889
chr4 39903879 chr2 235548889
chr4 39969479 chr2 237312989
chr4 55043679 chr2 237320789
chr4 55146079 chr3 1594750
chr4 56296879 chr3 1848450
chr4 68815379 chr3 4077050
chr4 72011079 chr3 4776250
chr4 73638979 chr3 4844350
chr4 74793579 chr3 5041350
chr4 74986179 chr3 8646150
chr4 75406079 chr3 8868850
chr4 77339295 chr3 9972250
chr4 77355495 chr3 11215550
chr4 79782595 chr3 11781950
chr4 88166195 chr3 12196050
chr4 89738895 chr3 15334950
chr4 100976195 chr3 17985250
chr4 109253095 chr3 20334550
chr4 110128695 chr3 21995950
chr4 111306195 chr3 22396450
chr4 124564495 chr3 23280550
chr4 145029195 chr3 24252850
chr4 145270995 chr3 24469850
chr4 152084995 chr3 24982350
chr4 153803695 chr3 25539950
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chr4 154097995 chr3 25609450
chr4 186325695 chr3 27151450
chr4 187802295 chr3 27623850
chr5 10339250 chr3 28968250
chr5 10778950 chr3 31379850
chr5 34904050 chr3 36800550
chr5 38414550 chr3 37338150
chr5 53634050 chr3 39547550
chr5 55355050 chr3 41670050
chr5 60168650 chr3 44902050
chr5 61101650 chr3 45143450
chr5 65301150 chr3 45195150
chr5 67139750 chr3 52646150
chr5 67710550 chr3 54351050
chr5 67781750 chr3 54625850
chr5 67887250 chr3 56063650
chr5 75789850 chr3 56989950
chr5 76182550 chr3 57976050
chr5 77839850 chr3 62670050
chr5 78935350 chr3 63992350
chr5 79142350 chr3 65956950
chr5 79178050 chr3 67664150
chr5 95233550 chr3 67780950
chr5 124069950 chr3 69357850
chr5 131672050 chr3 69565850
chr5 134585050 chr3 71048450
chr5 134801450 chr3 71588550
chr5 141639950 chr3 72294050
chr5 141649950 chr3 73023950
chr5 145418750 chr3 78869350
chr5 148421350 chr3 88941850
chr5 148800850 chr3 90339950
chr5 149025950 chr3 100094850
chr5 149109050 chr3 100868550
chr5 149141150 chr3 101234450
chr5 149149750 chr3 104287350
chr5 149870850 chr3 106553550
chr5 150366850 chr3 113887350
chr5 150385050 chr3 114298550
chr5 154146550 chr3 114354050
chr5 156905550 chr3 118726150
chr5 159599950 chr3 121620350
chr5 169027050 chr3 124819750
chr5 169063050 chr3 124921250
chr5 169697550 chr3 125478350
chr5 172167250 chr3 125995150
chr5 173096550 chr3 126226350
chr5 173112950 chr3 126247650
chr5 173131850 chr3 126266650
chr5 173200250 chr3 127822842
chr5 176868350 chr3 128993942
chr5 177913650 chr3 129585142
chr5 178221750 chr3 130858942
chr6 7073750 chr3 133162642
chr6 7114150 chr3 133211742
chr6 10696750 chr3 133336942
chr6 13468350 chr3 138157342
chr6 13503850 chr3 142562442
chr6 14727150 chr3 149937042
chr6 14871750 chr3 150797442
chr6 15205650 chr3 151220842
chr6 15375150 chr3 151549542
chr6 15878250 chr3 153600542
chr6 16024550 chr3 154110642
chr6 16095550 chr3 154252542
chr6 17977450 chr3 156503842
chr6 20581550 chr3 158323242
chr6 21372450 chr3 166349442
chr6 26873850 chr3 168291542
chr6 28206050 chr3 170465042
chr6 29073450 chr3 171925342
chr6 29717550 chr3 172011342
chr6 29725250 chr3 173275842
chr6 30857450 chr3 173506842
chr6 31663050 chr3 179024442
chr6 34607050 chr3 179182542
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chr6 34935750 chr3 186738142
chr6 35435650 chr3 186997842
chr6 36833850 chr3 187414742
chr6 36926550 chr3 188264342
chr6 37137050 chr3 188410542
chr6 37206550 chr3 189157742
chr6 39264250 chr3 189547642
chr6 39281850 chr3 190507342
chr6 40454750 chr3 191277142
chr6 42121150 chr3 191735242
chr6 43875350 chr3 195258342
chr6 43946850 chr3 198577837
chr6 44087650 chr3 198677637
chr6 51033550 chr4 1899817
chr6 52589350 chr4 4269479
chr6 53288850 chr4 6444579
chr6 80235150 chr4 6579879
chr6 80377450 chr4 7410879
chr6 89013050 chr4 7976879
chr6 119508750 chr4 8013279
chr6 119619550 chr4 9643579
chr6 119688150 chr4 10140879
chr6 126207850 chr4 12463779
chr6 134424850 chr4 12523479
chr6 135555650 chr4 13905079
chr6 135688450 chr4 14016679
chr6 135710450 chr4 14247379
chr6 137524150 chr4 14844979
chr6 139881850 chr4 16297079
chr6 147274650 chr4 22650879
chr6 147278750 chr4 22994879
chr6 159176729 chr4 23194079
chr6 159196229 chr4 23738979
chr7 705392 chr4 23819679
chr7 878435 chr4 23821979
chr7 2630435 chr4 23953079
chr7 8140135 chr4 26094379
chr7 12746635 chr4 27584579
chr7 17212635 chr4 30438679
chr7 22409535 chr4 36070279
chr7 29679635 chr4 36795879
chr7 30765135 chr4 37740979
chr7 30926835 chr4 39933779
chr7 30943135 chr4 40212479
chr7 33005735 chr4 40816779
chr7 44984035 chr4 40874779
chr7 45033135 chr4 41264379
chr7 50997835 chr4 45643679
chr7 64042935 chr4 54637979
chr7 64661235 chr4 55054279
chr7 64981935 chr4 55592579
chr7 66282035 chr4 56881479
chr7 71888535 chr4 57625679
chr7 72211435 chr4 58064179
chr7 73345035 chr4 65332579
chr7 75063635 chr4 66200779
chr7 75876535 chr4 67103579
chr7 95703935 chr4 74061779
chr7 99625635 chr4 83656695
chr7 99810835 chr4 86637495
chr7 100526435 chr4 88601495
chr7 100532635 chr4 89710895
chr7 100586335 chr4 89947595
chr7 101163935 chr4 90579695
chr7 103409935 chr4 94323895
chr7 105627935 chr4 100940895
chr7 106444935 chr4 102178195
chr7 106485435 chr4 102351495
chr7 107664235 chr4 110128795
chr7 112572035 chr4 110254595
chr7 129437235 chr4 113134295
chr7 132331235 chr4 114776095
chr7 138770335 chr4 117874995
chr7 138938235 chr4 119574195
chr7 139264535 chr4 119966995
chr7 148031035 chr4 120178495
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chr7 150534935 chr4 121147895
chr7 150568835 chr4 121622495
chr7 150757135 chr4 124041095
chr7 150838335 chr4 125343695
chr7 151015635 chr4 128281895
chr8 2499550 chr4 129526395
chr8 2633250 chr4 129531295
chr8 17969950 chr4 129917895
chr8 22102050 chr4 134735295
chr8 23435650 chr4 139100495
chr8 23542550 chr4 140735795
chr8 27277450 chr4 141883995
chr8 27279150 chr4 142072995
chr8 27353250 chr4 142199295
chr8 53782250 chr4 143514195
chr8 91242150 chr4 150299995
chr8 101512950 chr4 151360295
chr8 101982150 chr4 153180095
chr8 102190850 chr4 157453395
chr8 102237750 chr4 160680095
chr8 103998650 chr4 166772395
chr8 104006950 chr4 167046895
chr8 106598250 chr4 169311495
chr8 123939250 chr4 169696895
chr8 124595250 chr4 169795995
chr8 124750950 chr4 174374195
chr8 125037950 chr4 176991795
chr8 125065750 chr4 177927895
chr8 125349750 chr4 178642795
chr8 125736250 chr4 183125495
chr8 125802250 chr4 184560395
chr8 125905650 chr4 184596395
chr8 125912350 chr4 186386995
chr8 126415550 chr4 186441895
chr8 126527450 chr4 186983495
chr8 128841650 chr5 14249850
chr8 128900750 chr5 14725150
chr8 128980650 chr5 15057350
chr8 129040350 chr5 15133450
chr8 129094750 chr5 17181050
chr8 129137650 chr5 17310650
chr8 129172250 chr5 24282250
chr8 129186750 chr5 24825750
chr8 129424050 chr5 29660550
chr8 129510050 chr5 31661750
chr8 130159850 chr5 32567750
chr8 130283350 chr5 35959950
chr8 130398450 chr5 36452650
chr8 130530650 chr5 38730350
chr8 130536550 chr5 41820450
chr8 130792750 chr5 43766550
chr8 131066650 chr5 52058150
chr8 134458150 chr5 52355750
chr8 134582050 chr5 52525150
chr8 143024450 chr5 53692350
chr9 70449816 chr5 54075250
chr9 70554716 chr5 56825850
chr9 72204116 chr5 57349750
chr9 76855416 chr5 58228850
chr9 94866916 chr5 58258650
chr9 95960016 chr5 58490250
chr9 96710616 chr5 58617850
chr9 98055616 chr5 58909150
chr9 99078916 chr5 59163150
chr9 99745216 chr5 60799650
chr9 99866816 chr5 64381250
chr9 99987916 chr5 64393650
chr9 100244716 chr5 64726550
chr9 100689616 chr5 65564850
chr9 100708116 chr5 65885450
chr9 100774716 chr5 71584150
chr9 100819416 chr5 83605050
chr9 100869416 chr5 83638550
chr9 101104816 chr5 86221450
chr9 109819616 chr5 88915050
chr9 109896416 chr5 90201850
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chr9 115381017 chr5 90250150
chr9 115687417 chr5 95681050
chr9 116287817 chr5 95692650
chr9 118222617 chr5 96011550
chr9 122739317 chr5 102145550
chr9 123087317 chr5 105837250
chr9 123890617 chr5 111701150
chr9 123981617 chr5 114824950
chr9 124024617 chr5 127351150
chr9 126063017 chr5 128441350
chr9 126702117 chr5 133867750
chr9 128932417 chr5 135255250
chr9 128969817 chr5 135380550
chr9 129342017 chr5 135421050
chr9 129363617 chr5 136442250
chr9 129917717 chr5 136673850
chr9 130487317 chr5 136834450
chr9 130993517 chr5 139002350
chr9 131398517 chr5 139113450
chr9 131665517 chr5 139671250
chr9 131681317 chr5 142242650
chr9 132401817 chr5 142468750
chr9 133502017 chr5 142603250
chr9 134644917 chr5 142902950
chr9 135007017 chr5 142921850
chr9 137539326 chr5 143694350
chr9 138262726 chr5 144842850
chr10 3796750 chr5 145189250
chr10 5976550 chr5 145284950
chr10 11253750 chr5 145900150
chr10 11787450 chr5 146082050
chr10 11792750 chr5 148151550
chr10 13786750 chr5 148322550
chr10 15394050 chr5 149472150
chr10 16552250 chr5 151044550
chr10 17500550 chr5 153716250
chr10 18086650 chr5 157881750
chr10 22808750 chr5 158287450
chr10 22945350 chr5 158355250
chr10 22949350 chr5 158823050
chr10 23090150 chr5 158903650
chr10 25036150 chr5 159209550
chr10 32089950 chr5 159224450
chr10 32235350 chr5 162607250
chr10 33278250 chr5 163563250
chr10 35046150 chr5 167059450
chr10 35080050 chr5 167306950
chr10 35764250 chr5 167532850
chr10 49340450 chr5 167629350
chr10 49368150 chr5 168016250
chr10 63224650 chr5 168480550
chr10 70762550 chr5 169455450
chr10 70887750 chr5 170960550
chr10 72047550 chr5 171314650
chr10 72695750 chr5 171996250
chr10 73067250 chr5 172155850
chr10 75338250 chr5 172220050
chr10 75481450 chr5 172246350
chr10 80613350 chr5 172926550
chr10 80617850 chr5 173154250
chr10 80819250 chr5 173162750
chr10 80898550 chr5 173707750
chr10 82022850 chr5 173743150
chr10 82248550 chr5 174053150
chr10 88573150 chr6 1209850
chr10 93339950 chr6 2448650
chr10 97253450 chr6 2557050
chr10 100207150 chr6 3690650
chr10 100215250 chr6 4304850
chr10 100527150 chr6 4978550
chr10 100670750 chr6 6623650
chr10 104531250 chr6 7648650
chr10 105324250 chr6 10418050
chr10 105331250 chr6 11229050
chr10 105364850 chr6 12710750
chr10 120999750 chr6 39256050
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chr10 121021250 chr6 39292450
chr10 126307150 chr6 41790050
chr10 126407650 chr6 44086850
chr10 134969359 chr6 98226050
chr11 5264650 chr6 106351950
chr11 5509950 chr6 109159950
chr11 10644550 chr6 112646350
chr11 12106150 chr6 113892850
chr11 12120950 chr6 117923450
chr11 12136550 chr6 122144850
chr11 15943450 chr6 124923350
chr11 15990850 chr6 126307050
chr11 18557350 chr6 130009150
chr11 33918550 chr6 132185950
chr11 34221050 chr6 132427050
chr11 34618150 chr6 133640250
chr11 34809550 chr6 136174850
chr11 36171050 chr6 138214350
chr11 44506650 chr6 139932550
chr11 44585850 chr6 143196050
chr11 46251450 chr6 145260550
chr11 47895450 chr6 146515450
chr11 56817450 chr6 149396050
chr11 60517550 chr6 149531250
chr11 62443850 chr6 149696850
chr11 64674650 chr6 150945929
chr11 66429050 chr6 153221229
chr11 68661950 chr6 155535329
chr11 71388350 chr6 159176729
chr11 72169450 chr6 167072429
chr11 72767050 chr6 167108129
chr11 72774750 chr7 1520635
chr11 73855550 chr7 1528035
chr11 74760950 chr7 1699035
chr11 74769450 chr7 3444135
chr11 74857550 chr7 5780635
chr11 74896150 chr7 6391535
chr11 74942950 chr7 8436835
chr11 76219350 chr7 10669735
chr11 76947050 chr7 11266535
chr11 78332850 chr7 12736535
chr11 85243450 chr7 12807935
chr11 85530150 chr7 14387635
chr11 85551350 chr7 20247135
chr11 85582750 chr7 20357635
chr11 94104550 chr7 20390635
chr11 94464750 chr7 20608335
chr11 94526050 chr7 21198835
chr11 95709050 chr7 22703235
chr11 112999450 chr7 23767135
chr11 113065350 chr7 24977835
chr11 113672850 chr7 27641635
chr11 116237050 chr7 28108435
chr11 117328750 chr7 28548235
chr11 124450250 chr7 30715635
chr12 624950 chr7 32048535
chr12 654150 chr7 33587835
chr12 2956650 chr7 33769535
chr12 2977750 chr7 33837835
chr12 3579450 chr7 33892835
chr12 4369450 chr7 34066935
chr12 6527250 chr7 34843835
chr12 7046650 chr7 36123335
chr12 12785950 chr7 36309335
chr12 13116550 chr7 37713735
chr12 13332950 chr7 37720035
chr12 19491850 chr7 42104535
chr12 23610850 chr7 43497435
chr12 31782250 chr7 44623435
chr12 44560750 chr7 46610635
chr12 45835750 chr7 47379335
chr12 48384850 chr7 48089335
chr12 48625250 chr7 55030835
chr12 48721850 chr7 68498635
chr12 48934550 chr7 79934235
chr12 50508050 chr7 80017835
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chr12 51316550 chr7 83509835
chr12 52033250 chr7 83804435
chr12 55777250 chr7 88070435
chr12 70710050 chr7 90092235
chr12 74402150 chr7 91152135
chr12 88244413 chr7 92217535
chr12 92039713 chr7 92292035
chr12 92339013 chr7 94776435
chr12 92557713 chr7 98660135
chr12 92702313 chr7 101163935
chr12 93084313 chr7 101703935
chr12 100746213 chr7 104391335
chr12 101337013 chr7 105851035
chr12 103195713 chr7 109961735
chr12 103443413 chr7 110625735
chr12 103641113 chr7 114002435
chr12 104799513 chr7 114011435
chr12 104812113 chr7 114899235
chr12 104873813 chr7 115604235
chr12 107009113 chr7 117086835
chr12 109021413 chr7 120161235
chr12 109289813 chr7 121466435
chr12 109502413 chr7 126127735
chr12 110282613 chr7 129797735
chr12 111759713 chr7 132848035
chr12 112679013 chr7 133700835
chr12 112704713 chr7 134169935
chr12 115108813 chr7 137109235
chr12 115205213 chr7 139406435
chr12 115309513 chr7 150838335
chr12 115533013 chr7 158591435
chr12 117547213 chr8 8146850
chr12 120453213 chr8 13172750
chr12 120671113 chr8 17738750
chr12 122113923 chr8 17798650
chr12 126129023 chr8 19509550
chr12 129887223 chr8 19979550
chr12 130003723 chr8 24873850
chr13 26648350 chr8 24909450
chr13 27634350 chr8 24936950
chr13 28104250 chr8 25117850
chr13 31881150 chr8 26484350
chr13 32270550 chr8 27589750
chr13 41036450 chr8 27870950
chr13 44668450 chr8 29469950
chr13 46114450 chr8 29710950
chr13 49374650 chr8 32781250
chr13 49861850 chr8 35123950
chr13 49898650 chr8 36634050
chr13 51160750 chr8 36858350
chr13 51429150 chr8 37605450
chr13 97957750 chr8 40335250
chr14 20837550 chr8 41123050
chr14 22336050 chr8 41162350
chr14 23812950 chr8 41301250
chr14 30577750 chr8 41484850
chr14 31549450 chr8 48488550
chr14 33450150 chr8 50375350
chr14 36705450 chr8 51120750
chr14 49625050 chr8 51130750
chr14 54292650 chr8 54334450
chr14 55334050 chr8 55527150
chr14 63930450 chr8 58623350
chr14 64378950 chr8 58827350
chr14 68265350 chr8 62667250
chr14 68284750 chr8 62830150
chr14 68296950 chr8 67582250
chr14 74421050 chr8 70674350
chr14 75465350 chr8 73110250
chr14 76660450 chr8 75370350
chr14 77447250 chr8 80863750
chr14 77451950 chr8 80908050
chr14 90918150 chr8 81509950
chr14 99581650 chr8 81991650
chr15 24954250 chr8 86923750
chr15 38177150 chr8 89286450
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chr15 38322950 chr8 90182050
chr15 38926050 chr8 95301150
chr15 42899450 chr8 95323150
chr15 47004850 chr8 96072950
chr15 53347850 chr8 96279650
chr15 54862250 chr8 96784650
chr15 56565250 chr8 96866150
chr15 56631750 chr8 97526050
chr15 57615250 chr8 97613550
chr15 61453050 chr8 97873250
chr15 61920950 chr8 98873250
chr15 61965550 chr8 99807350
chr15 65104750 chr8 101574950
chr15 66285150 chr8 102199850
chr15 67069550 chr8 102274350
chr15 68171850 chr8 103837250
chr15 68182250 chr8 103870050
chr15 73663550 chr8 104006950
chr15 73713950 chr8 107860050
chr15 73839250 chr8 107939650
chr15 76339250 chr8 109657350
chr15 78027650 chr8 117810350
chr15 79154250 chr8 119093050
chr15 83337050 chr8 119181050
chr15 87571350 chr8 119877950
chr15 89814250 chr8 121486150
chr15 91166050 chr8 121838550
chr15 94463450 chr8 122612450
chr15 94736950 chr8 123936550
chr16 10624350 chr8 124774250
chr16 11073950 chr8 124801350
chr16 11627250 chr8 125295750
chr16 15169950 chr8 126313850
chr16 23798850 chr8 126341250
chr16 24913450 chr8 126676150
chr16 30327550 chr8 128560850
chr16 45983950 chr8 128648350
chr16 48844050 chr8 128841750
chr16 48872250 chr8 128933950
chr16 55737150 chr8 129051250
chr16 56283150 chr8 129208650
chr16 67363350 chr8 129265750
chr16 69317950 chr8 129605350
chr16 73681050 chr8 131345150
chr16 77993550 chr8 131602350
chr16 80060450 chr8 131824750
chr16 80105550 chr8 134129550
chr16 80134750 chr8 134131150
chr16 80216150 chr8 134457450
chr16 83344750 chr8 134755450
chr16 83808150 chr8 138228250
chr16 84154850 chr8 142123050
chr16 85849550 chr9 71276216
chr16 87061450 chr9 71915916
chr16 88047750 chr9 72688516
chr17 1468450 chr9 73484316
chr17 3738350 chr9 74384716
chr17 4686650 chr9 77244616
chr17 7321050 chr9 78622516
chr17 8264250 chr9 79750616
chr17 13351450 chr9 83353916
chr17 13436250 chr9 83648416
chr17 15369950 chr9 83653016
chr17 17809650 chr9 88358216
chr17 17913550 chr9 88418816
chr17 18661650 chr9 88501416
chr17 19060150 chr9 88626916
chr17 22929750 chr9 88789816
chr17 22985050 chr9 89075816
chr17 23344350 chr9 96451216
chr17 23877350 chr9 97882916
chr17 24217150 chr9 98414616
chr17 24511750 chr9 99331016
chr17 25064050 chr9 99987816
chr17 26822650 chr9 100584416
chr17 28180050 chr9 100607516
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K562 HeLa
Chromosome Position Chromosome Position
chr17 29278850 chr9 100609616
chr17 29294150 chr9 100663916
chr17 29299750 chr9 100711316
chr17 32041950 chr9 100785616
chr17 35523750 chr9 101889216
chr17 35847850 chr9 102377616
chr17 35942950 chr9 107723016
chr17 36930050 chr9 109371416
chr17 37820950 chr9 109896416
chr17 38156350 chr9 110073416
chr17 40924250 chr9 110280116
chr17 42197350 chr9 110411316
chr17 42243050 chr9 111378916
chr17 42321150 chr9 111830616
chr17 45311750 chr9 113762516
chr17 45484550 chr9 115759217
chr17 45587050 chr9 116083917
chr17 52912150 chr9 116287417
chr17 53798950 chr9 116521517
chr17 55522250 chr9 116696717
chr17 59662850 chr9 116907517
chr17 68269350 chr9 117094217
chr17 68806650 chr9 117610217
chr17 68826050 chr9 117781217
chr17 68982150 chr9 117810217
chr17 71150350 chr9 117898017
chr17 74217150 chr9 118021117
chr18 771850 chr9 118038817
chr18 957350 chr9 118072317
chr18 8978850 chr9 120121017
chr18 19374750 chr9 120335317
chr18 51180050 chr9 120764317
chr18 52450250 chr9 122284017
chr18 58255450 chr9 122486117
chr18 66110450 chr9 122526017
chr19 2099650 chr9 122739217
chr19 2674050 chr9 124186017
chr19 3084650 chr9 125141917
chr19 5041750 chr9 126193417
chr19 5894250 chr9 126581317
chr19 8181850 chr9 126621417
chr19 10372650 chr9 127315717
chr19 10907150 chr9 129524217
chr19 11511550 chr9 131209017
chr19 13821950 chr9 131275817
chr19 17923650 chr9 132647817
chr19 17941150 chr9 132860417
chr19 37811450 chr9 133533717
chr19 40157550 chr9 133598717
chr19 40611350 chr9 135346917
chr19 44529350 chr9 138025126
chr19 47629450 chr10 3457950
chr19 50294350 chr10 6994850
chr19 52294150 chr10 14167250
chr19 52378350 chr10 16726450
chr19 59125483 chr10 19426050
chr20 615450 chr10 22949350
chr20 1014950 chr10 33339050
chr20 1053950 chr10 33680350
chr20 1194650 chr10 35087350
chr20 1401350 chr10 46582850
chr20 2038250 chr10 48151350
chr20 2819150 chr10 51815050
chr20 13846050 chr10 59447050
chr20 23020550 chr10 61036750
chr20 29646750 chr10 61814450
chr20 29758150 chr10 62445850
chr20 29765750 chr10 65129650
chr20 30211150 chr10 71697150
chr20 30731950 chr10 72685750
chr20 30782150 chr10 73654050
chr20 31493650 chr10 79340150
chr20 32114950 chr10 80401950
chr20 32300650 chr10 80837950
chr20 32353350 chr10 80918450
chr20 34174650 chr10 81914150
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K562 HeLa
Chromosome Position Chromosome Position
chr20 35911750 chr10 82248650
chr20 36225350 chr10 85733850
chr20 36420250 chr10 89813150
chr20 36902950 chr10 90224450
chr20 39220750 chr10 90308150
chr20 41381250 chr10 90561050
chr20 42605150 chr10 91028250
chr20 42653750 chr10 93421550
chr20 43354750 chr10 95191950
chr20 43897750 chr10 95219550
chr20 44047450 chr10 95495950
chr20 44636450 chr10 95755950
chr20 46850150 chr10 96437150
chr20 46904650 chr10 99324750
chr20 46936850 chr10 100064950
chr20 47231050 chr10 112253450
chr20 47799650 chr10 112552950
chr20 47860950 chr10 112878850
chr20 47918650 chr10 113428150
chr20 48196450 chr10 113614450
chr20 48342450 chr10 113832050
chr20 48357050 chr10 114275250
chr20 48370350 chr10 115502250
chr20 48397950 chr10 120774750
chr20 48543350 chr10 132309150
chr20 48570750 chr11 8205650
chr20 48687150 chr11 8229350
chr20 48865150 chr11 9506750
chr20 49540250 chr11 10636550
chr20 51673850 chr11 12756150
chr20 51837850 chr11 12777850
chr20 54908350 chr11 16174250
chr20 60456150 chr11 19349150
chr21 15494050 chr11 19637950
chr21 29612150 chr11 23519250
chr21 29946350 chr11 27096050
chr21 30043650 chr11 27151250
chr21 34318150 chr11 27195750
chr21 34325750 chr11 29278350
chr21 34382850 chr11 33680950
chr21 35463150 chr11 33682750
chr21 37182950 chr11 33684750
chr21 37739150 chr11 33877550
chr21 37869350 chr11 34751950
chr21 39054150 chr11 35352250
chr21 39260750 chr11 37481650
chr21 42708850 chr11 40492550
chr21 42847950 chr11 43915550
chr21 43982150 chr11 47922050
chr21 45371250 chr11 47994750
chr22 17657896 chr11 48127950
chr22 20181896 chr11 56367050
chr22 20511196 chr11 56430250
chr22 20827496 chr11 56597250
chr22 23171696 chr11 56801250
chr22 23621096 chr11 57917450
chr22 24128496 chr11 59901650
chr22 25298896 chr11 60037250
chr22 25307596 chr11 61924650
chr22 25355296 chr11 62032450
chr22 25384396 chr11 63132850
chr22 25860396 chr11 63801150
chr22 26320696 chr11 64674650
chr22 27617596 chr11 65546050
chr22 28427496 chr11 66509450
chr22 28477496 chr11 66579050
chr22 28506696 chr11 68655550
chr22 28539796 chr11 69048850
chr22 29865496 chr11 71511850
chr22 30012196 chr11 72652850
chr22 30626396 chr11 72956150
chr22 30662896 chr11 73568250
chr22 31376696 chr11 73657750
chr22 33770496 chr11 74760950
chr22 34109696 chr11 77646150
chr22 34173196 chr11 78131050
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K562 HeLa
Chromosome Position Chromosome Position
chr22 34383696 chr11 80220350
chr22 34960796 chr11 80592250
chr22 35081996 chr11 80838250
chr22 35158196 chr11 83046050
chr22 35734696 chr11 83081350
chr22 35913396 chr11 83163250
chr22 35955196 chr11 84207450
chr22 36289296 chr11 85435650
chr22 36621496 chr11 85505450
chr22 36992396 chr11 85582650
chr22 37498696 chr11 85940950
chr22 37709596 chr11 86322450
chr22 37767996 chr11 87773550
chr22 38447696 chr11 87927950
chr22 38571196 chr11 91295150
chr22 38692696 chr11 94506250
chr22 40265996 chr11 94654150
chr22 40323696 chr11 95373550
chr22 40335296 chr11 95592350
chr22 40507396 chr11 95682450
chr22 41443196 chr11 95704250
chr22 43223777 chr11 98086350
chr22 46438595 chr11 98425050
chrX 153012097 chr11 99928450
chrY 24763013 chr11 109228350
Table ST4: Lists of genomic locations of core loci of MIR-enhancers
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Figure C.1: Composite regulatory elements and their features in the human
genome. Functional genomic profiles of fold enrichments of individual histone mod-
ifications around (A) composite B+E elements and (B) simple B-E elements. (C,D)
Enrichment profiles and average fold enrichments for DNAse hypersensitive sites and
RNA-seq reads in-and-around boundary elements (blue bars).
116
Figure C.2: Composite regulatory elements and the KEGG chemokine sig-
naling pathway. Chemokine signaling pathway genes(yellow) located or having
close homologs proximal to B+E elements
117
0 1 2 3
B+E
B-E
Counts vs expected log2 fold enrichment  































 Hypergeometric test of enrichment -log10(P-value) 


















Voltage-gated potassium ion channels 
Symbol Description 
KCNJ1 Potassium inwardly-rectifying channel, subfamily J, member 1 
KCNJ12 Potassium inwardly-rectifying channel, subfamily J, member 12 
KCNJ18 Potassium inwardly-rectifying channel, subfamily J, member 18 
KCNJ5 Potassium inwardly-rectifying channel, subfamily J, member 5 
KCNJ8 Potassium inwardly-rectifying channel, subfamily J, member 8 
KCNMB1 Potassium large conductance calcium-activated channel, 
subfamily M, beta member 1 
KCNN4 Potassium intermediate/small conductance calcium-activated 
channel, subfamily N, member 4 
KCTD16 Potassium channel tetramerization domain-containing protein 16 
Figure C.3: Composite regulatory elements and Voltage-gated potassium
ion channels. (A) Voltage-gated K+ ion channel complex genes proximal to com-
posite (B+E) regulatory elements. (B) Enrichment of Voltage-gated K+ channel
complex genes for composite (B+E) versus canonical (B-E) boundary elements. (C)
Voltage-gated K+ ion channels predominantly associated with B+E elements. GIRK
(G protein-activated inwardly rectifying potassium channels) (dark blue) which per-
form inward potassium channel transportation and SK4 (Small conductance calcium-
activated potassium channels) (light blue) which perform outward potassium channel
transportation. Ligand (purple) binding to G protein-coupled receptor (gray) release
activated G-protein βγ-subunits (βγ)which activate the GIRK receptors (blue) to
draw in K+ ions. Ca2+ activates SK4 channels to export K+ ions.
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Table ST5: Copmposite cis-regulatory elements in CD4+ cell-line
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Gene expression quintiles 
2nd 3rd 4th 
low high 
Figure D.1: Gene expression-based percentage DNA methylation around
the TSS, gene-body and TTS.(A) Average percentage methylation levels of 100bp
windows spanning the TSS, gene-body and TTS, showing 3kb and 5kb upstream and
downstream of TSS respectively and 5kb and 3kb upstream and downstream of TTS
respectively. (B) Overall percentage methylation levels of groups of genes binned by






































Figure D.2: A non-monotonic relationship between gene-body DNA methy-
lation and gene expression. Shows overall percentage methylation of gene-bodies
(regions starting at 1kb downstream of the TSS and ending at 1kb upstream of the
TTS). Each data point represents the average methylation and corresponding average







TSS Gene Body TTS















TSS Gene Body TTS











Gene expression quintiles 





0 3 6 9














0 3 6 9












Figure D.3: The bell shaped relationship between gene-body DNA methy-
lation and gene expression is independent of gene length. Methylation levels
for 5 gene expression bins at the TSS, gene-body and TTS for the 20% shortest (A)
and 20% longest (B) genes. Relationship between gene-body DNA methylation and
gene expression for 100 gene expression bins in the 20% shortest (C) and 20% longest




















Figure D.4: Comparison between genic and intergenic DNA methylation levels in





























































































r = 0.68 
P = 3.6e-15 
r = 0.62 
P = 3.0e-12 
r = 0.71 
P = 6.7e-17 
r = 0.84 
P = 4.5e-28 
r = 0.72 
P = 1.6e-17 
r = 0.76 
P = 2.4e-20 
Figure D.5: Relationship between gene expression and-.(A) Polymerase II den-
sity and (B) Density of DNaseI hypersensitive sites. Each data point represents the
average Pol2 or average DHSS and the corresponding average gene expression of a bin
of genes. Bins of genes are ordered by their average gene expression level. Pearson
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